Movatterモバイル変換


[0]ホーム

URL:


US6654638B1 - Ultrasonically activated electrodes - Google Patents

Ultrasonically activated electrodes
Download PDF

Info

Publication number
US6654638B1
US6654638B1US09/545,104US54510400AUS6654638B1US 6654638 B1US6654638 B1US 6654638B1US 54510400 AUS54510400 AUS 54510400AUS 6654638 B1US6654638 B1US 6654638B1
Authority
US
United States
Prior art keywords
piezoelectric element
pacing
energy
anode
cathode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US09/545,104
Inventor
Robert J. Sweeney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiac Pacemakers Inc
Original Assignee
Cardiac Pacemakers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiac Pacemakers IncfiledCriticalCardiac Pacemakers Inc
Priority to US09/545,104priorityCriticalpatent/US6654638B1/en
Assigned to CARDIAC PACEMAKERS, INC.reassignmentCARDIAC PACEMAKERS, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: SWEENEY, ROBERT J.
Priority to AU2001251304Aprioritypatent/AU2001251304A1/en
Priority to PCT/US2001/010961prioritypatent/WO2001076687A2/en
Application grantedgrantedCritical
Publication of US6654638B1publicationCriticalpatent/US6654638B1/en
Anticipated expirationlegal-statusCritical
Expired - Fee Relatedlegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

An implantable electrode, where the electrode comprises a first piezoelectric element which converts mechanical energy into electrical energy, and a cathode and an anode, where electrical energy generated by the first piezoelectric element causes a pacing level energy pulse to be delivered between the anode and the cathode. The mechanical energy for stimulating the piezoelectric element originates from a source external to the implantable electrode. In one embodiment, the external source is from a transmitter that is located on, or integrated into, either a cardiac lead and/or the implantable pulse generator. The electrode further includes an implantable housing into which is integrated the first piezoelectric element and on which is mounted the anode and the cathode. The housing also contains pacing control circuitry, which is coupled to the first piezoelectric element, the anode and the cathode. In one embodiment, the pacing control circuitry serves to receive the electrical energy generated by the first piezoelectric element and control the delivery of pacing level energy pulse between the anode and the cathode.

Description

FIELD OF THE INVENTION
This invention relates generally to medical devices, and more particularly to pulse generating systems.
BACKGROUND
Implantable pulse generators (e.g., pacemakers, implantable cardioverter/defibrillators) are integrated highly sophisticated electro-mechanical systems. They typically comprise at least one implantable cardiac lead coupled to a pulse generating device. The implantable cardiac leads serve to physically and electrically connect the pulse generating device, including the electronic circuitry housed within the device, to pacing electrodes positioned on the implantable cardiac lead. The implantable cardiac lead, therefore, acts as a tether to connect the pacing electrodes on the cardiac lead to the implantable pulse generating device.
Implantable cardiac leads typically include at least one pacing electrode, a lead conductor, lead insulation, and a lead connector. When one pacing electrode is present on the implantable cardiac lead, it is typically placed at the distal end of the lead. The lead conductor physically and electrically couples the pacing electrode to the electronic circuitry of the pulse generator. The lead conductor serves to conduct pacing level energy pulses from the electronic circuitry to the pacing electrode, and to conduct cardiac signals sensed by the pacing electrode to the electronic circuitry.
The lead conductor is housed within the lead insulation. The lead insulation electrically isolates the lead conductor, allowing the pacing level energy pulses from the pulse generator to be delivered to the pacing electrode and cardiac signals from the pacing electrode to be delivered to the electronic circuitry of the pulse generator. The lead connector also serves to physically couple the implantable cardiac lead to the housing of the pulse generator. Thus, the current state of the art for implantable pulse generators is to use the lead conductor to pass electrical pacing pulses to the pacing electrode when delivering pacing pulses to the heart.
The size of implantable cardiac leads is often a limiting factor in where the implantable cardiac lead can be positioned within the heart. Typically, implantable cardiac leads have been implanted through the venous side of the circulatory system, with the distal end of the cardiac lead being positioned in either the right ventricle or right atrium. Implantable cardiac leads can also be positioned adjacent the left atrium or left ventricle by placing the lead in the coronary sinus or great cardiac vein. Regardless of the location, the pacing electrodes are always tethered to the pulse generator by cardiac lead. As a result, sites available for cardiac pacing by implantable cardiac leads are limited. Thus, a need exists whereby implanted electrodes for delivering electrical energy to cardiac tissue need not be constrained by the presence of a cardiac lead.
SUMMARY OF THE INVENTION
The present subject matter removes the limitation of the pacing electrode being coupled, or tethered, to the implantable cardiac lead. In one embodiment, there are provided self-contained electrodes which are adapted to receive at least one signal from a transmitter. In response to receiving the at least one signal, the self-contained electrodes generate and deliver an electrical energy pulse. In one embodiment, the electrical energy pulses are pacing level energy pulses. Thus, the present subject matter allows for the physical connection between the implantable cardiac lead and the pacing electrode to be severed. By severing the physical connection between the implantable cardiac lead and the pacing electrode, the self-contained electrodes of the present subject matter are able to be placed at any number of locations within the cardiac tissue without the limiting constraint of the traditional implantable cardiac lead.
In one embodiment, present subject matter provides an implantable electrode, where the electrode comprises a first piezoelectric element which converts mechanical energy into electrical energy, and a cathode and an anode, where electrical energy generated by the first piezoelectric element causes a pacing level energy pulse to be delivered between the anode and the cathode. In one embodiment, the mechanical energy for stimulating the piezoelectric element originates from a source external to the implantable electrode. In one embodiment, the external source is from a transmitter that is located on, or integrated into, either a cardiac lead and/or the implantable pulse generator.
In one embodiment, the implantable electrode includes an implantable housing into which is integrated the first piezoelectric element. The housing also includes an anode and a cathode positioned the peripheral surface of the housing. The housing also contains pacing control circuitry, which is coupled to the first piezoelectric element, the anode and the cathode. In one embodiment, the pacing control circuitry serves to receive the electrical energy generated by the first piezoelectric element and control the delivery of pacing level energy pulse between the anode and the cathode.
In an additional embodiment, the implantable electrode can further include a potential energy source (e.g., an electrochemical cell) which supplies at least a portion of the energy necessary to pace the cardiac tissue. In addition to the potential energy source, the pacing control circuitry can further include a switch, where the switch is operated by the electrical energy generated by the first piezoelectric element. In one embodiment, the switch is activated so as to deliver a pulse between the anode and cathode when the switch receives electrical energy generated by the first piezoelectric element.
In an alternative embodiment, the implantable electrode can further include a second piezoelectric element which converts mechanical energy into electrical energy. When a first and second piezoelectric element are present, each element is selected to resonate in a different frequency range, so that the first piezoelectric element resonates at a first frequency range and the second piezoelectric element resonates at a second frequency range. The implantable electrode further includes both the switch and a capacitor. In one embodiment, the switch is coupled to the first piezoelectric element, the second piezoelectric element, the anode and the cathode, and the capacitor is coupled to the switch.
Electrical energy is generated by the first piezoelectric element when a first transmission at the first frequency range resonates the first piezoelectric element and electrical energy is generated by the second piezoelectric element when a second transmission at the second frequency range resonates the second piezoelectric element, where the electrical energy is stored in the capacitor. The switch is then used to cause the pacing level energy pulse to be delivered between the anode and the cathode when a predetermined pulse signal is detected. In one embodiment, the predetermined pulse signal is a predetermined frequency change in the first frequency range. Alternatively, the predetermined pulse signal is a predetermined frequency change in the first and second frequency ranges.
In an alternative embodiment, the pacing control circuitry includes a switch, where the switch is operated by the electrical energy generated by the first piezoelectric element, and a potential energy source, where the potential energy source is coupled to the switch and supplies electrical energy to be delivered between the anode and the cathode once the first piezoelectric element provides electrical energy to activate the switch.
These and other features and advantages of the invention will become apparent from the following description of the preferred embodiments of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows one embodiment of a system according to the present subject matter;
FIG. 2 shows one embodiment of a system according to the present subject matter;
FIG. 3 shows one embodiment of a system according to the present subject matter;
FIG. 4 shows one embodiment of a system according to the present subject matter;
FIG. 5 shows one embodiment of an electrode according to the present subject matter;
FIG. 6 shows one embodiment of an electrode according to the present subject matter;
FIG. 7 shows a block diagram of one embodiment of the present subject matter;
FIG. 8 shows a block diagram of one embodiment of the present subject matter; and
FIG. 9 shows embodiments of transmissions according to the present subject matter.
DETAILED DESCRIPTION
In the following detailed description, reference is made to the accompanying drawings which form a part hereof and in which is shown by way of illustration specific embodiments in which the invention can be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice and use the invention, and it is to be understood that other embodiments may be utilized and that electrical, logical, and structural changes may be made without departing from the spirit and scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense and the scope of the present invention is defined by the appended claims and their equivalents.
Implantable pulse generators (e.g., pacemakers, implantable cardioverter/defibrillators) are integrated highly sophisticated electro-mechanical systems. They typically comprise at least one implantable cardiac lead coupled to a pulse generating device. The implantable cardiac leads serve to physically and electrically connect the pulse generating device, including the electronic circuitry housed within the device, to pacing electrodes positioned on the implantable cardiac lead. The implantable cardiac lead, therefore, acts as a tether to connect the pacing electrodes on the cardiac lead to the implantable pulse generating device.
Implantable cardiac leads typically include at least one pacing electrode, a lead conductor, lead insulation, and a lead connector. When one pacing electrode is present on the implantable cardiac lead, it is typically placed at the distal end of the lead. The lead conductor physically and electrically couples the pacing electrode to the electronic circuitry of the pulse generator. The lead conductor serves to conduct pacing level energy pulses from the electronic circuitry to the pacing electrode, and to conduct cardiac signals sensed by the pacing electrode to the electronic circuitry.
The lead conductor is housed within the lead insulation. The lead insulation electrically isolates the lead conductor, allowing the pacing level energy pulses from the pulse generator to be delivered to the pacing electrode and cardiac signals from the pacing electrode to be delivered to the electronic circuitry of the pulse generator. The lead connector also serves to physically couple the implantable cardiac lead to the housing of the pulse generator. Thus, the current state of the art for implantable pulse generators is to use the lead conductor to pass electrical pacing pulses to the pacing electrode when delivering pacing pulses to the heart.
The size of implantable cardiac leads is often a limiting factor in where the implantable cardiac lead can be positioned within the heart. Typically, implantable cardiac leads have been implanted through the venous side of the circulatory system, with the distal end of the cardiac lead being positioned in either the right ventricle or right atrium. Implantable cardiac leads can also be positioned adjacent the left atrium or left ventricle by placing the lead in the coronary sinus or great cardiac vein. Regardless of the location, the pacing electrodes are always tethered to the pulse generator by cardiac lead. As a result, sites available for cardiac pacing by implantable cardiac leads are limited.
The present subject matter relates to a system that removes the limitation of a pacing electrode being coupled, or tethered, to an implantable cardiac lead. In one embodiment, there are provided self-contained electrodes which are adapted to receive at least one signal from a transmitter. In response to receiving the at least one signal, the self-contained electrodes generate and deliver to the heart an electrical energy pulse. In one embodiment, the electrical energy pulses are pacing level energy pulses. Thus, the present subject matter allows for the physical connection between the implantable cardiac lead and the pacing electrode to be severed. By severing the physical connection between the implantable cardiac lead and the pacing electrode, the self-contained electrodes of the present subject matter are able to be placed at any number of locations within the cardiac tissue without the limiting constraint of the traditional implantable cardiac lead.
FIG. 1 shows an embodiment of a system of the present subject matter. The system includes animplantable pulse generator10 to which is physically and electrically coupled atransvenous catheter14. In one embodiment, theimplantable pulse generator10 is a pacemaker. Alternatively, theimplantable pulse generator10 is an implantable cardioverter/defibrillator. In one embodiment, thetransvenous catheter14 includes atransmission element16, which is adapted to transmit mechanical signals. In one embodiment, the mechanical signals include signals in the ultrasonic frequency range. The system further includes animplantable pacing electrode18. Theimplantable pacing electrode18 receives the mechanical signals transmitted by thetransmission element16. In response to receiving the mechanical signals, theimplantable pacing electrode18 generates and/or produces electrical energy which this to be delivered between an anode and a cathode surface on theimplantable pacing electrode18. In one embodiment, mechanical signals from thetransmission element16 are transmitted to two or moreimplantable pacing electrodes18.
In one embodiment, theimplantable pulse generator10 of the present subject matter is an implantable pacemaker. Alternatively, theimplantable pulse generator10 of the present subject matter is an implantable cardiac defibrillator. In addition, thetransvenous catheter14 further includes one or more pacing electrodes and/or one or more defibrillation electrodes. One example is shown in FIG. 1 in which thetransvenous catheter14 is shown with a distaltip pacing electrode24. Additional pacing/sensing electrodes can also be positioned along the body of thetransvenous catheter14 and coupled to theimplantable pulse generator10 to allow for additional pacing and sensing activity.
In one embodiment, theimplantable pulse generator10 includes input circuitry to receive cardiac signals sensed by pacing electrodes, such as pacingelectrode24. The input circuitry is coupled to morphology analyzing circuitry which analyzes cardiac signals received through the input circuitry. In one embodiment, one or more electrochemical batteries are housed within theimplantable pulse generator10 and supply electrical energy to output circuitry for delivering pacing level energy pulses to the pacing electrodes coupled to thetransvenous catheter14 under the control of the morphology analyzing circuitry. Theimplantable pulse generator10 further includes transmission circuitry coupled to the output circuitry for supplying energy to thetransmission element16.
Upon receiving the energy from the transmission circuitry, thetransmission element16 produces one or more mechanical signals which are transmitted from thetransmission element16. In one embodiment, thetransmission element16 is a piezoelectric element which is adapted to cause mechanical energy to be delivered to theimplantable pacing electrode18 so as to allow theimplantable pacing electrode18 to generate and deliver one or more electrical pulses.
FIG. 1 shows one embodiment where thetransmission element16 is located along the body of thetransvenous catheter14. Thetransmission element16 is positioned along thetransvenous catheter14 to allow for thetransmission element16 to be positioned in any number of locations within a heart which is accessible to atransvenous catheter14. For example, thetransmission element16 is positioned along thecatheter14 to allow for theelement16 to be positioned within a right atrial chamber of the heart. In an alternative embodiment, thetransmission elements16 can be positioned along thetransvenous catheter14 to position the transmission element in any number of locations accessible to a transvenous catheter. For example,transmission element16 can be located along thetransvenous catheter14 to position the transmission element in a supraventricular location of a heart. In an additional embodiment, thetransmission element16 may be located along thetransvenous catheter14 at or adjacent adistal end32 of thetransvenous catheter14.Transvenous catheter14 could then be inserted through the coronary sinus vein to locate thetransmission element16 adjacent to either the left atrial chamber of the left ventricular chamber of the heart.
Theimplantable pacing electrode18 is adapted to receive mechanical energy transmitted from a transmission source which is external of theimplantable pacing electrode18. In one embodiment, the transmission source is thetransmission element16 located along thetransvenous catheter14. In an alternative embodiment, the transmission source is located within or on thehousing34 of theimplantable pulse generator10. In an alternative embodiment, the transmission source is located at a remote site which is neither on thetransvenous catheter14 or associated with thehousing34. Upon receiving the mechanical energy, theimplantable pacing electrode18 converts the mechanical energy into electrical energy. The electrical energy generated within theimplantable pacing electrode18 is then used to cause a pacing level electrical energy pulse to be delivered across an anode and a cathode position on theimplantable pacing electrode18.
In one embodiment, the mechanical signal is an ultrasonic signal transmitted from thetransmission element16. In one embodiment, thetransmission element16 is a piezoelectric element, where the piezoelectric element is coupled to the transmission circuitry located within theimplantable pulse generator10. The transmission circuitry is adapted to drive thetransmission element16 to produce an ultrasonic signal from the piezoelectric element. In one embodiment, the ultrasonic signal produced by thetransmission element16 is transmitted omnidirectionally. The directionality of ultrasonic transmission from a piezoelectric element depends on its physical dimensions (size and aspect ratio), its transmission mode (full wave, ¼ wave, etc.), and its coupling with the conduction medium. In one embodiment, the transmission element is constructed to transmit directionally and the ultrasonic signal produced by thetransmission element16 is directed in the direction of the implanted pacingelectrode18. In an alternative embodiment, the element is constructed to have less directional transmissions so that one or more pacing elements might be affected. In one embodiment, the transmission element delivers energy in a low frequency range, where a low frequency range is approximately one to five (1 to 5) megahertz, where one (1) megahertz is an acceptable value.
Besides being located on the catheter or within the housing of theimplantable pulse generator10, thetransmission element16 can be mounted within theheader36 of theimplantable pulse generator10. In a further embodiment, thetransmission element16 is coupled to theimplantable pulse generator10 through the use of an electrical lead, when thetransmission element16 is positioned subcutaneously in a position adjacent the heart of the patient.
In one embodiment, theimplantable pacing electrodes18 includes a piezoelectric element that is tuned to resonate in a specific frequency range. Atransmission element16 is provided that transmits ultrasonic frequencies in the resonance frequency range of theimplantable pacing electrode18. Upon receiving the ultrasonic signal, the piezoelectric element of theimplantable pacing electrode18 generates electrical energy which is used to cause a pacing level energy pulse to be delivered between an anode and a cathode on the implantable pacing electrode.
In an additional embodiment, more than one transmission element (e.g., more than one piezoelectric element) can be utilized in developing the ultrasonic signal to activate theimplantable pacing electrode18. For example, a first transmission element is positioned on theimplantable pulse generator10, and a second transmission element is positioned on thetransvenous catheter14. Alternatively, a first transmission element is located on or within theimplantable pulse generator10 and a second transmission element is coupled through a lead to theimplantable pulse generator10 and implanted subcutaneously adjacent to the heart. Other combinations of two or more transmission elements are also possible and considered within the scope of the present subject matter. Furthermore, each of the transmission elements can be adapted to transmit a signal at an individualized frequency range. For example, a first transmission element is adapted to transmit a first signal in a first frequency range and a second transmission element is adapted to transmit a second signal in a second frequency range. Each of the one ormore elements18 is then adapted to respond to the first and second frequency ranges as will be more fully described below.
Referring now to FIG. 2 there is shown an additional embodiment of the present subject matter. FIG. 2 shows theimplantable pulse generator10 coupled to thetransvenous catheter14 and to asecond transvenous catheter200. Thesecond transvenous catheter200 includes at least one pacing electrode physically and electrically coupled to theimplantable pulse generator10. In the embodiment, thesecond transvenous catheter200 is implanted in the supraventricular region of the heart to allow for cardiac signals to be sensed from and pacing pulses to be delivered to the supraventricular region of the heart. In an alternative embodiment, thesecond transvenous catheter200 is adapted to be implanted through the coronary sinus vein to position the pacing electrodes adjacent to the left atrium or to the left ventricular region of the heart. In an additional embodiment, thesecond catheter200 can include two or more pacing electrodes, where such catheter structures are known and are considered to be within the scope of the present subject matter.
In one embodiment, thetransvenous catheter14 and thesecond transvenous catheter200 are implanted into the heart and then coupled to theimplantable pulse generator10. Theimplantable pulse generator10 is then implanted subcutaneously in the body. In one embodiment, thetransvenous catheter14 includes a distaltip pacing electrode202 and asecond pacing electrode204. In one embodiment, thesecond pacing electrode204 is an annular or semi-annular ring electrode which is positioned proximal to the distal tip of pacingelectrode202 to allow for bipolar pacing and sensing from thetransvenous catheter14. Thesecond transvenous catheter200 also includes adistal tip electrode206. Thedistal tip electrode206 can be used for unipolar sensing and pacing between thedistal tip electrode206 and thehousing208 of theimplantable pulse generator10.
In the embodiment of FIG. 2, theimplantable pulse generator10 is shown having thetransmission element16 associated with thehousing208 of theimplantable pulse generator10. In one embodiment, thetransmission element16 is positioned within thehousing208 of theimplantable pulse generator10. Additionally, thetransmission element16 can also be positioned on or within aconnector block214 of theimplantable pulse generator10. In addition to associating thetransmission element16 with thehousing208, matching layers of material are used in association with thetransmission element16 to improve the acoustic coupling between the piezo-electric crystal (one possible material for the transmission element16) and the conducting medium (i.e., the body). Additionally, matching layers can be added to additional portions of theimplantable pulse generator10 which are in contact with tissue. Regardless of the position of thetransmission element16, the output of thetransmission element16 is directed towards theimplantable pacing electrodes18.
In the embodiment shown in FIG. 2, two or moreimplantable pacing electrodes18 positioned within a transmission range of thetransmission element16. In one embodiment, the two or moreimplantable pacing electrodes18 are implanted within a heart. When two or moreimplantable pacing electrodes18 are used, eachimplantable pacing electrode18 includes a piezoelectric element that is tuned to resonate at a different frequency. In one embodiment, this allowsimplantable pacing electrodes18 to be selectively paced by transmitting mechanical signals of theimplantable pacing electrode18 specific resonate frequency from thetransmission element16. In one embodiment, atransmission element16 can deliver a series of signals having different frequencies where each frequency triggers or causes separateimplantable pacing electrode18 elements to deliver pacing pulses to the heart28. This type of configuration allows two or moreimplantable pacing electrodes18 to deliver pacing pulses in an ordered or specific pattern. In one embodiment, selectively and sequentially activating two or moreimplantable pacing electrodes18 allows the heart to contract in a more forceful and efficient matter.
In an additional embodiment, two or moreimplantable pacing electrodes18 can be implanted in the supraventricular region and in the ventricular region of the heart. Theimplantable pacing electrodes18 implanted in the supraventricular region can be tuned to resonate at a first frequency, and theimplantable pacing electrodes18 implanted in the ventricular region can be tuned to resonate at a second frequency. Thetransmission element16 can then transmit a first signal to cause theimplantable pacing electrodes18 implanted in the atria to deliver a first pacing pulse. Thetransmission element16 can subsequently deliver a second signal to cause theimplantable pacing electrodes18 implanted in the ventricular region to deliver a second pacing pulse. In addition to including multipleimplantable pacing electrodes18, two ormore transmission elements16 can be included with two or moreimplantable pacing electrodes18. In one embodiment, each of the two ormore transmission elements16 can be tuned to deliver signals in frequency ranges that correspond to the different frequency ranges, or resonate frequencies of theimplantable pacing electrodes18. In this manner, each of thetransmission elements16 can be designated for one or more of theimplantable pacing electrodes18 implanted in the heart28.
Referring now to FIG. 3 there is shown an embodiment of a block diagram of animplantable pulse generator10. Theimplantable pulse generator10 includeselectronic control circuitry300 for receiving cardiac signals from the heart and delivering electrical energy to the heart. In one embodiment, pacing electrodes located on the transvenous catheter are electrically connected to input circuitry304 by the lead conductors housed within thetransvenous catheter14. In one embodiment, the input circuitry304 includes electrical surge protection circuitry and one or more amplifiers as are known. In one embodiment, the one or more amplifiers are electrically connected to cardiacwave detection circuitry308 bybus310. In one embodiment, the cardiacwave detection circuitry308 includes an R-wave detector when a transvenous catheter is implanted in the right ventricle chamber of the heart. The cardiacwave detection circuitry308 can also include a P-wave detector when a second transvenous catheter is implanted in the supraventricular region of the heart and then coupled to theimplantable pulse generator10. These components serve to sense and amplify the R-waves and P-waves of the heart and apply signals indicative thereof to morphology analyzingcircuitry312.
In one embodiment, themorphology analyzing circuitry312 is a programmable microprocessor-based system, which contains memory circuitry having parameters for various pacing and sensing modes. Themorphology analyzing circuits312 also store data indicative of the cardiac signals received by the input circuitry304. Communications circuity316 is additionally coupled to themorphology analyzing circuitry312 bybus310.Communications circuitry316 allows theimplantable pulse generator10 to communicate with aprogrammer unit320. In one embodiment,communications circuit316 and theprogrammer unit320 use a wire loop antenna and a radio frequency telemetry link, as is known in the art, to receive and transmit command signals and data to and from theprogrammer unit320 and theelectronic control circuitry300. In this manner, programming commands or instructions are transferred to theelectronic control circuitry300 of theimplantable pulse generator10.
Themorphology analyzing circuitry312 responds to sense cardiac signals by providing signals to output control circuitry324. In one embodiment, the output circuitry324 provides pacing level electrical energy to the heart. Power to theimplantable pulse generator10 is supplied by apotential energy source328 which is housed within theimplantable pulse generator10. In one embodiment, thepotential energy source328 is a electrochemical battery as is known in the art. Theelectronic control circuitry300 further includestransmission circuitry340. In one embodiment,transmission circuitry340 controls the mechanical signals delivered by one or more of the transmission elements. In one embodiment, thetransmission circuitry340 controls which transmission element is activated, how long the transmission element is activated, and at what level of intensity the transmission element is activated. Thetransmission circuitry340 is coupled to theelectronic control circuitry300 and receives command and control signals from themorphology analyzer312 bybus310. Themorphology analyzing circuitry312 responds to cardiac signals sensed within the heart by providing signals to either the output circuitry324 or to thetransmission circuitry340 to cause pacing level energy pulses to be delivered to the heart through either the pacing electrodes attached to one or more transvenous catheters and/or theimplantable pacing electrodes18.
In one embodiment, theelectronic control circuitry300 of theimplantable pulse generator10 is encased and hermetically sealed in ahousing330 suitable for implanting in a human body. Aconnector block334 is additionally attached to the housing of theimplantable pulse generator10 to allow for physical and electrical attachment of one or more transvenous catheters and the electrodes to theimplantable generator10 and the encasedelectronic control circuitry300.
In one embodiment, thetransvenous catheter14 includes a distal tip pacing electrode. This allows the transvenous catheter to sense rate signals, or near field signals, from the ventricle region of the heart. In an alternative embodiment, two or more pacing electrodes can be included on thetransvenous catheter14 to allow for bipolar sensing and pacing. In an additional embodiment, pacing electrodes can be located on both a first transvenous catheter and a second transvenous catheter when two catheters are implanted into the heart. This allows for near field signals to be sensed both from the ventricle and the supraventricular region of the patient's heart. Other intracardiac catheter arrangements and configurations known in the art are also possible and considered to be within the scope of the present system.
Referring now to FIG. 4, there is shown several embodiments of a transmission element in association with animplantable pulse generator10. In one embodiment, thetransmission circuitry340 is coupled to atransmission element400 which is positioned within thehousing410 of theimplantable pulse generator10. The transmission element could also be positioned on an exterior portion of thehousing410 of theimplantable pulse generator10. Atransmission element430 is shown coupled to thetransmission circuitry340 through the use of atransmission lead440. Thetransmission lead440 physically and electrically couples thetransmission element430 to thetransmission circuits340 through the use of theconnector block450. Thetransmission element430 can be implanted subcutaneously at a position adjacent the heart. Alternatively, thetransmission element430 can be positioned subcutaneously in any position that allows for the mechanical signal to best reach the implanted pacing electrodes of interest. As previously mentioned, one or more transmission elements can also be positioned within or on theconnector block450. Also, matching layers can be used in conjunction with thetransmission element430, as previously described.
Referring now to FIG. 5, there is shown an embodiment of theimplantable pacing electrode18. Theimplantable pacing electrode18 includes acathode500 and ananode502. Theimplantable pacing electrode18 includes ahousing504. In one embodiment, thehousing504 is the piezoelectric element of theimplantable pacing electrode18. Alternatively, the piezoelectric element is contained within thehousing504. The piezoelectric element is adapted to receive mechanical energy and convert the mechanical energy into electrical energy where the mechanical energy originates from a source external to theimplantable pacing electrode18. In one embodiment, the external source is thetransmission element16 previously described. In an alternative embodiment, the external source is a source located outside of the patient's body. The electrical energy generated by the piezoelectric element then causes a pacing level energy pulse to be delivered between thecathode500 and theanode502.
Thehousing504 is constructed of a material suitable for implanting into the human body. In one embodiment, thehousing504 is a cylinder, or elongate segment, of piezoelectric element, where circuitry for controlling theimplantable pacing electrode18 is contained within the cylinder. The piezoelectric element can also have matching layers to improve the acoustic coupling between the element of theelectrode18 and the tissue in which it is embedded. In an alternative embodiment, the piezoelectric and control circuitry are embedded inhousing504 which is constructed of an acoustically conductive material, such as an epoxy resin.
In an additional embodiment,implantable pacing electrode18 includes an active fixation element. In one embodiment, the active fixation includes tines positioned on the peripheral surface of theelectrode18. Alteratively, a hook can be used, where the hook can have, or be, either the anode or cathode of theelectrode18. Additionally, the hook can include one or more barbs. In one embodiment, theelectrode18 is approximately five (5) to fifteen (15) millimeters in length (along longitudinal axis) and approximately one (1) to four (4) millimeters in diameter. In one embodiment, the electrode is six (6) millimeters in length and has a diameter of three (3) millimeters. Additionally, theelectrode18 can have any number of shapes including, but not limited to, spherical, tubular, cylindrical, and elliptical. In an alternative embodiment, theimplantable pacing electrode18 can have any shape that is suitable for housing the pacing control circuitry and the piezoelectric element, and which has a peripheral surface that is suitable to accept an anode and a cathode of sufficient size and shape to deliver pacing energy pulses.
In one embodiment, the piezoelectric element of theelectrode18 is tuned, or selected, to resonate in a low frequency range, where the low frequency range is approximately in the range of between 1-5 megahertz, where one megahertz is an acceptable value. Alternatively, the frequency range is approximately 250 kilohertz to 20 megahertz, where 750 kilohertz to 7.5 megahertz is a range to be used. Additionally, the pacing pulses generated by theimplantable pacing electrode18 are controlled by delivering short duration pulses of ultrasonic energy, where each pulse of ultrasonic energy is used to create a pacing level pulse by theimplantable pacing electrode18. For example, it is known that cardiac tissue may be stimulated with a small pacing pulse of 2 milliseconds that delivers 5 to 10 microjoules. If the receiver only received energy during the 2 millisecond pacing pulse duration, then it would need to receive 2.5 to 5 microjoules per millisecond which is a reception power of 2.5 to 5 milliwatts. Assuming no losses, if the receiver had a 30 square millimeter cross-sectional area (e.g., 5 millimeter wide by 6 millimeter long) and was 5 centimeter from an omni-directional transmitter, then the transmission power would need to be about 2.5 to 5 Watts. In one embodiment, the short duration pulses are programmable values in the range of 0.5 to 10 millisecond, where 2 milliseconds is an acceptable value.
In an alternative embodiment, instead of delivering the pacing pulses only while the ultrasonic transmission from the transmission unit is underway, the implanted pacingelectrode18 stores the received energy over time and then delivers that energy as a pacing pulse when the transmission is stopped (e.g., when the transmission has stopped for approximately 10 milliseconds, the stored energy is delivered as a pacing pulse). With a maximum pacing rate of approximately 180 beats/minute, the same no-losses calculations requires the transmission power to be about 30 milliwatts or less. In one embodiment, circuitry in the implanted pacing electrode that is powered by the stored energy, detects the presence of a period without transmissions and then delivers the stored energy as a pacing pulse. In one embodiment, the charging duration and transmission power is timed to a cardiac cycle so as to ensure that theimplantable pacing electrode18 is prepared to deliver a pacing pulse when necessary.
Referring now to FIG. 6, there is shown one embodiment of theimplantable pacing electrode18 the present subject matter. In one embodiment, theimplantable pacing electrode18 includes acathode600 and ananode604. Theimplantable pacing electrode18 further includes ahousing608 that is suitable for implantation into the cardiac tissue of a human. As previously described, thehousing608 can be constructed of the piezoelectric element. Theanode604 and thecathode600 are positioned on the peripheral surface of thehousing608. Mounted within thehousing608 is pacingcontrol circuitry612. Thepacing control circuitry612 is coupled to theanode604 and thecathode600 and the piezoelectric element, where in this embodiment the piezoelectric element is thehousing608. The piezoelectric element receives mechanical energy from a source external to theimplantable pacing electrode18 and generates electrical energy to cause a pacing level energy pulse to be delivered between thecathode600 and theanode604. In the present embodiment, a fullwave bridge rectifier622 is used with the piezoelectric element to generate the pacing level energy pulse.
Referring now to FIG. 7, there is shown an alternative embodiment ofpacing control circuitry700. In one embodiment, thepacing control circuitry700 includes apiezoelectric element702, where thepiezoelectric element702 is electrically coupled to thepacing control circuitry700. Thepacing control circuitry700 further includes aswitch706 and apotential energy source708. Thepiezoelectric element702 and thepotential energy source708 are electrically coupled to theswitch706. In the present embodiment, thepiezoelectric element702 is used to generate a switching signal, where the switching signal is the electrical energy generated from thepiezoelectric element702. Upon receiving mechanical energy from a transmission element, thepiezoelectric element702 transmits the switching signal to theswitch706. After receiving the switching signal, theswitch706 is switched on, causing electrical energy to flow from thepotential energy source708 which causes a pacing level energy pulse to be delivered across the cathode and anode to the heart. In one embodiment, theswitch706 is a metal oxide semiconductor field effect transistor.
In one embodiment, thepotential energy source708 is an electrochemical battery. In an alternative embodiment, thepotential energy source708 is created by a half-cell potential difference between the metal of the anode and the metal of the cathode. In an alternative embodiment, thepotential energy source708 is a recharged on a beat-to-beat basis by the half-cell potential difference between the surrounding interstitial fluids and the metals of the anode and cathode. Metals useful for the present subject matter include, but are not limited to, platinum-iridium, titanium, gold, and/or stainless steel.
In a further embodiment, the pacing control circuitry includes a capacitor, where the electrical energy generated by the half cell potential is stored in the capacitor. The electrical energy stored in the capacitor is then delivered to the heart as a pacing pulse when the piezoelectric element delivers the switching signal to theswitch706. In an additional embodiment, the implantable electrode further includes a third electrode positioned on the peripheral surface of the implantable housing, where the third electrode is constructed of a metal that is different than the anode or the cathode metal. In one embodiment, the third electrode is composed of a metal that provides a larger half cell potential between the anode or the cathode than is possible between the cathode and anode.
In an additional embodiment, theimplantable pacing electrode18 includes two piezoelectric elements, where each piezoelectric element has a different resonance frequency. The two piezoelectric elements are coupled to the pacing control circuitry where the first piezoelectric element and the second piezoelectric element can receive mechanical signals from the transmission element, or elements, to charge the capacitor. In one embodiment, the transmission element, or elements, alternates transmitting ultrasonic energy that is suitable for resonating the first piezoelectric element and transmitting ultrasonic energy that is suitable for resonating the second piezoelectric element. In other words, the transmission element sends out ultrasonic frequencies that alternate between frequencies that resonate the first piezoelectric element and the second piezoelectric element. As each of the piezoelectric elements are excited they generate electrical energy to charge the capacitor which is coupled within the pacing control circuitry.
When a pacing pulse is to be delivered to the heart, the transmission element(s) delivers ultrasonic energy at a frequency that will resonate both the first piezoelectric element and the second piezoelectric element simultaneously. When both piezoelectric elements are excited simultaneously, the signals are then used to activate theswitch706 causing the energy stored in the capacitor to be delivered and pace the cardiac tissue of the patient. It is recognized that the two frequencies would need to be sufficiently different so that ultrasonic energy delivered at a first frequency to resonate a first piezoelectric element would not significantly effect a second piezoelectric element that is adapted to resonate at a second frequency. As such, the resonant frequency of the first and the second piezoelectric element must not be harmonics of each other. In addition, requiring both first and second piezoelectric elements to be stimulated simultaneously in order to deliver the pacing pulses, adds a safety feature to theimplantable pacing electrode18, as the chances of having an external source of mechanical energy capable of resonating both the first and the second piezoelectric elements simultaneously is significantly less than encountering a single external source that would resonate either the first or the second piezoelectric element.
In an alternative embodiment, the first frequency is used to cause the first piezoelectric element to charge the capacitor. The second frequency is then used to control a switch to cause the capacitor to supply a pacing level pulse to the anode and cathode of theimplantable pacing electrode18. One aspect to this use of a second frequency is that the risk of inappropriate release by external ultrasonic sources is reduced since the external source would now need to match two dissimilar frequencies instead of just one. For these concepts, the implanted device would be adapted to produce ultrasonic transmissions at both frequencies.
In a further embodiment, theimplantable pacing electrode18 has two or more piezoelectric elements, where each piezoelectric element has a different resonance frequency. The two piezoelectric elements are coupled to the pacing control circuitry where each of the two or more piezoelectric elements receive mechanical signals from the transmission element, or elements, to charge the capacitor. In one embodiment, the transmission element, or elements, continuously transmit ultrasonic energy that is suitable for resonating each of the piezoelectric elements. As each of the piezoelectric elements are excited they generate electrical energy to charge the capacitor which is coupled within the pacing control circuitry.
In one embodiment, when a pacing pulse is to be delivered to the heart one or more of the transmission elements stop transmitting for a predetermined time interval. In one embodiment, a switch coupled to the piezoelectric elements and the discharge capacitor monitors the continuous flow of energy from the piezoelectric elements. When the flow of one or more of the elements is interrupted for more than the predetermined time interval the switch triggers the capacitor to discharge a pacing level pulse of energy between the anode and cathode of theimplantable pacing electrode18.
Alternatively, the switch is adapted to monitor the ultrasonic transmission for breaks, or interruptions, in the ultrasound transmission. When the switch detects an interruption in the transmission greater than the predetermined time interval the switch controls the capacitor to discharge a pacing level pulse of energy between the anode and cathode of theimplantable pacing electrode18. In one embodiment, the predetermined time interval is a programmable value in the range of ten (10) to fifty (50) milliseconds, with 10 milliseconds being an acceptable value.
In an additional embodiment, the switch controls the capacitor to supply a pacing pulse once the switch detects a sudden increase of ultrasonic intensity in one or more of the multiple frequencies. Alternatively, the switch detects sudden increases in the energy output of one or more of the piezoelectric elements due to a sudden increase of ultrasonic intensity in one or more of the multiple frequencies. Once the switch detects one or more of these sudden increases, it controls the capacitor to supply pacing pulses. Alternatively, the switch could be adapted to detect a combination of breaks and increases at the different frequencies which would signal a pacing pulse is to be delivered. Finally, a transmission at an entirely different frequency which creates a signal from an additional piezoelectric element could be used to trigger the delivery of a pacing pulse.
Referring now to FIG. 8, there is shown an additional embodiment of the present subject matter. As previously discussed, theimplantable pacing electrode18 had been controlled by activating the ultrasound transmission for a short duration (about two milliseconds) to generate and deliver a pacing level pulse and then off for the remainder of the cardiac cycle. In the present embodiment, the ultrasound transmission is continuous so as to provide a continuous source of mechanical energy (or power) to the receiving element, or elements, within theimplantable pacing electrode18.
FIG. 8 shows one embodiment ofpacing control circuitry800, which includes at least onepiezoelectric element802. Thepacing control circuitry800 further includes acapacitor806 and aswitch810. In one embodiment, thecapacitor806 is adapted to store the electrical energy generated as thepiezoelectric element802 receives the continuous ultrasound transmissions. The energy stored in thecapacitor806 is then used to provide pacing pulses across the anode and cathode of theimplantable pacing electrode18. In one embodiment, the energy from thecapacitor806 is used to deliver the pacing level pulses when the continuous ultrasound transmission to thepiezoelectric element802 is interrupted for a predetermined time interval. In one embodiment, theswitch810 monitors the continuous flow of energy from thepiezoelectric element802. When the flow is interrupted for more than the predetermined time interval theswitch810 triggers thecapacitor806 to discharge a pacing level pulse of energy between the anode and cathode of theimplantable pacing electrode18.
Alternatively, theswitch810 is adapted to monitor the ultrasonic transmission for breaks, or interruptions, in the ultrasound transmission. When theswitch810 detects an interruption in the transmission greater than the predetermined time interval theswitch810 controls thecapacitor806 to discharge a pacing level pulse of energy between the anode and cathode of theimplantable pacing electrode18. In one embodiment, the predetermined time interval is as previously described.
In an additional embodiment, it is possible to use two or more frequencies in a multiplexed fashion, where each of the frequencies resonates a separate piezoelectric element contained within two or moreimplantable pacing electrodes18. The ultrasonic transmissions at the different frequencies are interleaved thus sharing the burden of charging the capacitor element in eachimplantable pacing electrode18. The triggering of the pacingelectrode18 to deliver pacing pulses is then accomplished by simultaneously transmitting a combination of frequencies which is specific for signaling an individualimplantable pacing electrode18 to deliver a pacing pulse.
Referring now to FIG. 9, there is shown an embodiment of the present subject matter. FIG. 9 shows a representation of a firstultrasonic transmission900, a secondultrasonic transmission910, and a thirdultrasonic transmission920 being transmitted to a first, second and third implantable pacing elements. At900, the first ultrasonic transmission is shown being pulsed at a first frequency, where the first frequency resonates the first implantable pacing element within each of the transmission elements causing it to generate electrical energy. At910, the second ultrasonic transmission is shown being pulsed at a second frequency, where the second frequency resonates the second implantable pacing element within each of the transmission elements causing it to generate electrical energy. Finally, at920 the third ultrasonic transmission is shown being pulsed at a third frequency, where the third frequency resonates the third implantable pacing element within each of the transmission elements causing it to generate electrical energy. In one embodiment, the first, second and third ultrasonic transmissions are staggered so that at any given time only one transmission is occurring, but the overall effect is to cause a continuous flow of electrical energy to be generated by the implantable pacing element.
Each of the transmissions serve to resonate one of the three piezoelectric elements in each of three implantable pacing elements. This results in the charging of the capacitor in each of the implantable pacing elements. When the implantable pacing elements are to be used to deliver pacing pulses different combinations of two of the frequencies are used to trigger the implantable pacing elements to deliver a pacing pulse. For example, the first implantable pacing element is triggered to deliver a pacing pulse when the firstultrasonic transmission900 and the second ultrasonic transmission occur together910, as shown at940. In the same manner, the second implantable pacing element is triggered to deliver a pacing pulse when the secondultrasonic transmission910 and the thirdultrasonic transmission920 occur together, as shown at950. Finally, the implantable pacing element is triggered to deliver a pacing pulse when the firstultrasonic transmission900 and the thirdultrasonic transmission920 occur together. This embodiment, therefore, allows for pacing to occur at two or more remote sites, where each of the remote pacing sites can be individually controlled by the combination of ultrasonic transmissions.
Alternatively, two or more implantable elements could be implanted in the same general location within the heart. By providing each of the two or more implantable elements with three or more piezoelectric elements that have individual resonance frequencies, ultrasonic transmissions can be delivered to continuously charge the capacitors. Additionally, each element can also be individually controlled to provide a pacing pulse. This allows for a first element to be discharged while the second element continues to charge. The first element then “skips” the next required pacing pulse as the second element is triggered to deliver the pulse. This allow for a longer time (e.g., a two cardiac cycle charging time) for each of the elements to prepare for delivering a pacing pulse. When three elements are used in a particular location, the present embodiment would allow for a three cardiac cycle charging time.
The energy that is accumulated and then triggered for release as a pacing stimulus does not necessarily need to come from the ultrasonic source in the implanted device. Rather it could be locally at the remote pacing element. For example, the mechanical action of the contracting heart could be utilized to produce electrical energy by compressing or deflecting a piezoelectric element that would serve to produce the charge for storage in a capacitor. It is also possible that high-frequency (10 to 50 kHz) low-voltage AC electrical signals could be passed over the heart by the implanted device. Because of the high-frequency, and low voltages, these signals would not excite the myocardial tissue. However, the remote pacing site could rectify the signals locally and use it as an energy source for charging a capacitor. In this arrangement, it makes sense for the two (or more) electrodes at the remote pacing site to be further apart so as to capture as much of the high-frequency AC field as possible. This could be accomplished by having the electrodes in the forms of short flexible wires.

Claims (17)

What is claimed is:
1. A system comprising:
a first piezoelectric element which converts mechanical energy into electrical energy, the mechanical energy which originates from a source external to an implantable electrode;
a cathode and an anode, where electrical energy generated by the first piezoelectric element causes a pacing level energy pulse to be delivered between the anode and the cathode; and
an implantable housing which includes a peripheral surface, where the first piezoelectric element is integrated with the housing, and the anode and the cathode are positioned at opposite sides on the peripheral surface of the housing.
2. The system ofclaim 1, further comprising pacing control circuitry coupled to the first piezoelectric element, the anode and the cathode such that the pacing control circuitry receives electrical energy generated by the first piezoelectric element and delivers pacing pulses between the anode and the cathode.
3. The system ofclaim 1, wherein the implantable housing includes an active fixation element.
4. A system comprising:
a first piezoelectric element which converts mechanical energy into electrical energy, the mechanical energy which originates from a source external to an implantable electrode;
a cathode and an anode, where electrical energy generated by the first piezoelectric element causes a pacing level energy pulse to be delivered between the anode and the cathode;
pacing control circuitry coupled to the first piezoelectric element, the anode and the cathode, where the pacing control circuitry receives electrical energy generated by the first piezoelectric element and delivers the pacing level energy pulse between the anode and the cathode;
where the pacing control circuitry includes:
a switch, where the switch is operated by the electrical energy generated by the first piezoelectric element; and
a potential energy source, where the potential energy source is coupled to the switch and supplies electrical energy to be delivered between the anode and the cathode once the first piezoelectric element provides electrical energy to activate the switch.
5. The system ofclaim 4, wherein the potential energy source is an electrochemical battery.
6. The system ofclaim 4, wherein the switch is a metal oxide field effect transistor.
7. A system comprising:
a first piezoelectric element which converts mechanical energy into electrical energy, the mechanical energy which originates from a source external to an implantable electrode;
a cathode and an anode, where electrical energy generated by the first piezoelectric element causes a pacing level energy pulse to be delivered between the anode and the cathode;
pacing control circuitry coupled to the first piezoelectric element, the anode and the cathode, where the pacing control circuitry receives electrical energy generated by the first piezoelectric element and delivers the pacing level energy pulse between the anode and the cathode; and
an implantable housing having a peripheral surface, where the pacing control circuitry is mounted within the housing, the first piezoelectric element is integrated with the housing, and the anode and the cathode are positioned at opposite sides on the peripheral surface of the housing.
8. The system ofclaim 7, wherein the implantable housing includes a second piezoelectric element which converts mechanical energy into electrical energy.
9. The system ofclaim 8, wherein the second piezoelectric element has a different resonance frequency than the first piezoelectric element.
10. A system comprising:
a first piezoelectric element which converts mechanical energy into electrical energy, the mechanical energy which originates from a source external to an implantable electrode;
a cathode and an anode, where electrical energy generated by the first piezoelectric element causes a pacing level energy pulse to be delivered between the anode and the cathode;
a second piezoelectric element which converts mechanical energy into electrical energy, where the first piezoelectric element resonates at a first frequency range and the second piezoelectric element resonates at a second frequency range; and
a switch and a capacitor, where the switch is coupled to the first piezoelectric element, the second piezoelectric element, the anode and the cathode, and the capacitor is coupled to the switch, where electrical energy is generated by the first piezoelectric element when a first transmission at the first frequency range resonates the first piezoelectric element and electrical energy is generated by the second piezoelectric element when a second transmission at the second frequency range resonates the second piezoelectric element, where the electrical energy is stored in the capacitor and the switch causes the pacing level energy pulse to be delivered between the anode and the cathode when a predetermined pulse signal is detected.
11. The system ofclaim 10, where the predetermined pulse signal is a predetermined frequency change in the first frequency range.
12. The system ofclaim 10, where the predetermined pulse signal is a predetermined frequency change in the first and second frequency ranges.
13. A system comprising:
a first piezoelectric element which converts mechanical energy into electrical energy, the mechanical energy which originates from a source external to an implantable electrode;
a cathode and an anode, where electrical energy generated by the first piezoelectric element causes a pacing level energy pulse to be delivered between the anode and the cathode; and
where the source includes a catheter having a transmission element adapted to transmit the mechanical signals to the first piezoelectric element, and a pulse generator, where the pulse generator includes a transmission circuit and where the transmission element is coupled to the transmission circuit to generate and transmit the mechanical energy to the first piezoelectric element.
14. The system ofclaim 13, where the transmission element transmits energy in a low frequency range of approximately one to five megahertz.
15. A method, comprising:
transmitting mechanical energy from a source external an implantable electrode;
receiving the mechanical energy within the implantable electrode;
generating electrical energy within the implantable electrode from the mechanical energy;
delivering pacing level energy pulse across an anode and a cathode positioned on the implantable electrode when the electrical energy is generated; and
where causing the pacing level energy pulse includes:
generating a switching signal from the electrical energy;
transmitting the switching signal to a switch coupled to a potential energy source; and
receiving the switching signal to activate the switch.
16. The method ofclaim 15, wherein delivering pacing level energy pulses across the anode and the cathode includes causing energy stored in a capacitor to be delivered to the anode and the cathode once the switch has been activated.
17. The method ofclaim 15, wherein delivering pacing level energy pulses across the anode and the cathode includes using energy created by the half-cell potential difference between metal of the anode and metal of the cathode.
US09/545,1042000-04-062000-04-06Ultrasonically activated electrodesExpired - Fee RelatedUS6654638B1 (en)

Priority Applications (3)

Application NumberPriority DateFiling DateTitle
US09/545,104US6654638B1 (en)2000-04-062000-04-06Ultrasonically activated electrodes
AU2001251304AAU2001251304A1 (en)2000-04-062001-04-04Ultrasonically activated electrodes
PCT/US2001/010961WO2001076687A2 (en)2000-04-062001-04-04Ultrasonically activated electrodes

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US09/545,104US6654638B1 (en)2000-04-062000-04-06Ultrasonically activated electrodes

Publications (1)

Publication NumberPublication Date
US6654638B1true US6654638B1 (en)2003-11-25

Family

ID=24174902

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US09/545,104Expired - Fee RelatedUS6654638B1 (en)2000-04-062000-04-06Ultrasonically activated electrodes

Country Status (3)

CountryLink
US (1)US6654638B1 (en)
AU (1)AU2001251304A1 (en)
WO (1)WO2001076687A2 (en)

Cited By (140)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20050222622A1 (en)*2002-02-112005-10-06Gold-T Tech, Inc.Method for preventing thrombus formation
US20060136005A1 (en)*2004-12-212006-06-22Ebr Systems, Inc.Implantable transducer devices
US20060136004A1 (en)*2004-12-212006-06-22Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US20060217767A1 (en)*2005-03-242006-09-28Kenergy, Inc.Implantable medical stimulation apparatus with intra-conductor capacitive energy storage
US20060253193A1 (en)*2005-05-032006-11-09Lichtenstein Samuel VMechanical means for controlling blood pressure
US20070060961A1 (en)*2005-09-122007-03-15Ebr Systems, Inc.Methods and apparatus for determining cardiac stimulation sites using hemodynamic data
US20070078490A1 (en)*2004-12-212007-04-05Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US20070142728A1 (en)*2003-04-142007-06-21Avi PennerApparatus and methods using acoustic telemetry for intrabody communications
WO2007027940A3 (en)*2005-08-312007-06-28Ebr Systems IncMethods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
US20070276444A1 (en)*2006-05-242007-11-29Daniel GelbartSelf-powered leadless pacemaker
US20070282383A1 (en)*2006-06-022007-12-06Semiconductor Energy Laboratory Co., Ltd.Cardiac pacemaker device
US20070293904A1 (en)*2006-06-202007-12-20Daniel GelbartSelf-powered resonant leadless pacemaker
WO2008011570A1 (en)*2006-07-212008-01-24Cardiac Pacemakers, Inc.Acoustic communication transducer in implantable medical device header
US20080021972A1 (en)*2006-07-212008-01-24Cardiac Pacemakers, Inc.System and method for addressing implantable devices
WO2008112577A1 (en)*2007-03-092008-09-18Proteus Biomedical, Inc.In-body device having a multi-directional transmitter
US20080288039A1 (en)*2007-05-172008-11-20Cardiac Pacemakers, Inc.Systems and methods for fixating transvenously implanted medical devices
US20080294208A1 (en)*2007-05-232008-11-27Ebr Systems, Inc.Optimizing energy transmission in a leadless tissue stimulation system
US7522962B1 (en)2004-12-032009-04-21Remon Medical Technologies, LtdImplantable medical device with integrated acoustic transducer
US20090171408A1 (en)*2005-12-122009-07-02Jan Otto SolemIntra Cardiac Device, System And Methods
US20090177251A1 (en)*2008-01-072009-07-09Paul HuelskampSystem And Method For In Situ Trimming Of Oscillators In A Pair Of Implantable Medical Devices
US7570998B2 (en)*2005-08-262009-08-04Cardiac Pacemakers, Inc.Acoustic communication transducer in implantable medical device header
US20090198307A1 (en)*2008-02-062009-08-06Bin MiDirect inductive/acoustic converter for implantable medical device
US7580750B2 (en)2004-11-242009-08-25Remon Medical Technologies, Ltd.Implantable medical device with integrated acoustic transducer
DE102008016364A1 (en)*2008-03-292009-10-01Biotronik Crm Patent Ag Signal line of an implantable electromedical device
WO2009120785A2 (en)2008-03-252009-10-01Ebr Systems, Inc.Implantable wireless acoustic stimulators with high energy conversion efficiencies
US7615012B2 (en)2005-08-262009-11-10Cardiac Pacemakers, Inc.Broadband acoustic sensor for an implantable medical device
US7621905B2 (en)1997-12-302009-11-24Remon Medical Technologies Ltd.Devices for intrabody delivery of molecules and systems and methods utilizing same
EP2123325A2 (en)2008-05-232009-11-25BIOTRONIK CRM Patent AGWireless execution for medical implants
US7634318B2 (en)2007-06-142009-12-15Cardiac Pacemakers, Inc.Multi-element acoustic recharging system
US7641619B2 (en)2000-10-162010-01-05Remon Medical Technologies, Ltd.Barometric pressure correction based on remote sources of information
US20100042177A1 (en)*2008-08-142010-02-18Cardiac Pacemakers, Inc.Performance assessment and adaptation of an acoustic communication link
US20100106011A1 (en)*2004-11-232010-04-29Charles Bryan ByrdMethod and apparatus for localizing an ultrasound catheter
US7742815B2 (en)2005-09-092010-06-22Cardiac Pacemakers, Inc.Using implanted sensors for feedback control of implanted medical devices
WO2010070650A1 (en)2008-12-212010-06-24Sirius Implantable Systems Ltd.High efficiency piezoelectric micro-generator and energy storage system
US20100234924A1 (en)*2008-03-252010-09-16Ebr Systems, Inc.Operation and estimation of output voltage of wireless stimulators
US7813808B1 (en)2004-11-242010-10-12Remon Medical Technologies LtdImplanted sensor system with optimized operational and sensing parameters
US7912548B2 (en)2006-07-212011-03-22Cardiac Pacemakers, Inc.Resonant structures for implantable devices
US20110077722A1 (en)*2002-08-192011-03-31Arizona Board of Regents, a body corporate acting and on behalf of Arizona State UniversityNeurostimulator
US7937148B2 (en)2005-10-142011-05-03Nanostim, Inc.Rate responsive leadless cardiac pacemaker
US7949396B2 (en)2006-07-212011-05-24Cardiac Pacemakers, Inc.Ultrasonic transducer for a metallic cavity implated medical device
US7953493B2 (en)2007-12-272011-05-31Ebr Systems, Inc.Optimizing size of implantable medical devices by isolating the power source
US7955268B2 (en)2006-07-212011-06-07Cardiac Pacemakers, Inc.Multiple sensor deployment
US7978064B2 (en)2005-04-282011-07-12Proteus Biomedical, Inc.Communication system with partial power source
US8036748B2 (en)2008-11-132011-10-11Proteus Biomedical, Inc.Ingestible therapy activator system and method
US8055334B2 (en)2008-12-112011-11-08Proteus Biomedical, Inc.Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8054140B2 (en)2006-10-172011-11-08Proteus Biomedical, Inc.Low voltage oscillator for medical devices
FR2960156A1 (en)*2010-05-192011-11-25Laurent BernemanImplantable electrode for use in cardiac pacemaker, has piezoelectric effect metal layer covered with thin film, where electrode is made of materials generating piezoelectric effect as primary or secondary energy source
US8082041B1 (en)*2007-06-152011-12-20Piezo Energy Technologies, LLCBio-implantable ultrasound energy capture and storage assembly including transmitter and receiver cooling
US8114021B2 (en)2008-12-152012-02-14Proteus Biomedical, Inc.Body-associated receiver and method
US8115618B2 (en)2007-05-242012-02-14Proteus Biomedical, Inc.RFID antenna for in-body device
US8258962B2 (en)2008-03-052012-09-04Proteus Biomedical, Inc.Multi-mode communication ingestible event markers and systems, and methods of using the same
US8271093B2 (en)2004-09-172012-09-18Cardiac Pacemakers, Inc.Systems and methods for deriving relative physiologic measurements using a backend computing system
US8369960B2 (en)2008-02-122013-02-05Cardiac Pacemakers, Inc.Systems and methods for controlling wireless signal transfers between ultrasound-enabled medical devices
US8527068B2 (en)2009-02-022013-09-03Nanostim, Inc.Leadless cardiac pacemaker with secondary fixation capability
US8543205B2 (en)2010-10-122013-09-24Nanostim, Inc.Temperature sensor for a leadless cardiac pacemaker
US8540633B2 (en)2008-08-132013-09-24Proteus Digital Health, Inc.Identifier circuits for generating unique identifiable indicators and techniques for producing same
US8540664B2 (en)2009-03-252013-09-24Proteus Digital Health, Inc.Probablistic pharmacokinetic and pharmacodynamic modeling
US8545402B2 (en)2009-04-282013-10-01Proteus Digital Health, Inc.Highly reliable ingestible event markers and methods for using the same
US8547248B2 (en)2005-09-012013-10-01Proteus Digital Health, Inc.Implantable zero-wire communications system
US8558563B2 (en)2009-08-212013-10-15Proteus Digital Health, Inc.Apparatus and method for measuring biochemical parameters
US8588926B2 (en)*2008-03-252013-11-19Ebr Systems, Inc.Implantable wireless accoustic stimulators with high energy conversion efficiencies
US8591423B2 (en)2008-10-102013-11-26Cardiac Pacemakers, Inc.Systems and methods for determining cardiac output using pulmonary artery pressure measurements
US8594806B2 (en)2010-04-302013-11-26Cyberonics, Inc.Recharging and communication lead for an implantable device
US8597186B2 (en)2009-01-062013-12-03Proteus Digital Health, Inc.Pharmaceutical dosages delivery system
US8615310B2 (en)2010-12-132013-12-24Pacesetter, Inc.Delivery catheter systems and methods
US8632470B2 (en)2008-11-192014-01-21Cardiac Pacemakers, Inc.Assessment of pulmonary vascular resistance via pulmonary artery pressure
US8718193B2 (en)2006-11-202014-05-06Proteus Digital Health, Inc.Active signal processing personal health signal receivers
US8725260B2 (en)2008-02-112014-05-13Cardiac Pacemakers, IncMethods of monitoring hemodynamic status for rhythm discrimination within the heart
US8730031B2 (en)2005-04-282014-05-20Proteus Digital Health, Inc.Communication system using an implantable device
US8784308B2 (en)2009-12-022014-07-22Proteus Digital Health, Inc.Integrated ingestible event marker system with pharmaceutical product
US8802183B2 (en)2005-04-282014-08-12Proteus Digital Health, Inc.Communication system with enhanced partial power source and method of manufacturing same
US8825161B1 (en)2007-05-172014-09-02Cardiac Pacemakers, Inc.Acoustic transducer for an implantable medical device
US8836513B2 (en)2006-04-282014-09-16Proteus Digital Health, Inc.Communication system incorporated in an ingestible product
US20140277231A1 (en)*2011-11-242014-09-18Laurent BernemanMedical device involving muscle stimulation electrodes and an electromagnetic lead
US8858432B2 (en)2007-02-012014-10-14Proteus Digital Health, Inc.Ingestible event marker systems
US8868453B2 (en)2009-11-042014-10-21Proteus Digital Health, Inc.System for supply chain management
US8912908B2 (en)2005-04-282014-12-16Proteus Digital Health, Inc.Communication system with remote activation
US8945005B2 (en)2006-10-252015-02-03Proteus Digital Health, Inc.Controlled activation ingestible identifier
US8956287B2 (en)2006-05-022015-02-17Proteus Digital Health, Inc.Patient customized therapeutic regimens
US8956288B2 (en)2007-02-142015-02-17Proteus Digital Health, Inc.In-body power source having high surface area electrode
US8961412B2 (en)2007-09-252015-02-24Proteus Digital Health, Inc.In-body device with virtual dipole signal amplification
US8974366B1 (en)2012-01-102015-03-10Piezo Energy Technologies, LLCHigh power ultrasound wireless transcutaneous energy transfer (US-TET) source
US9014779B2 (en)2010-02-012015-04-21Proteus Digital Health, Inc.Data gathering system
US9020611B2 (en)2010-10-132015-04-28Pacesetter, Inc.Leadless cardiac pacemaker with anti-unscrewing feature
US9060692B2 (en)2010-10-122015-06-23Pacesetter, Inc.Temperature sensor for a leadless cardiac pacemaker
US9107806B2 (en)2010-11-222015-08-18Proteus Digital Health, Inc.Ingestible device with pharmaceutical product
US9126032B2 (en)2010-12-132015-09-08Pacesetter, Inc.Pacemaker retrieval systems and methods
US9149423B2 (en)2009-05-122015-10-06Proteus Digital Health, Inc.Ingestible event markers comprising an ingestible component
US9168383B2 (en)2005-10-142015-10-27Pacesetter, Inc.Leadless cardiac pacemaker with conducted communication
US9198608B2 (en)2005-04-282015-12-01Proteus Digital Health, Inc.Communication system incorporated in a container
US9216280B1 (en)2011-10-112015-12-22A-Hamid HakkiEndovascular electrode system for tissue stimulation
US9235683B2 (en)2011-11-092016-01-12Proteus Digital Health, Inc.Apparatus, system, and method for managing adherence to a regimen
US9242102B2 (en)2010-12-202016-01-26Pacesetter, Inc.Leadless pacemaker with radial fixation mechanism
US9270503B2 (en)2013-09-202016-02-23Proteus Digital Health, Inc.Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9268909B2 (en)2012-10-182016-02-23Proteus Digital Health, Inc.Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9270025B2 (en)2007-03-092016-02-23Proteus Digital Health, Inc.In-body device having deployable antenna
US9271897B2 (en)2012-07-232016-03-01Proteus Digital Health, Inc.Techniques for manufacturing ingestible event markers comprising an ingestible component
US9283392B2 (en)2008-03-252016-03-15Ebr Systems, Inc.Temporary electrode connection for wireless pacing systems
US9289612B1 (en)2014-12-112016-03-22Medtronic Inc.Coordination of ventricular pacing in a leadless pacing system
US9399140B2 (en)2014-07-252016-07-26Medtronic, Inc.Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing
US9439599B2 (en)2011-03-112016-09-13Proteus Digital Health, Inc.Wearable personal body associated device with various physical configurations
US9439566B2 (en)2008-12-152016-09-13Proteus Digital Health, Inc.Re-wearable wireless device
US9452286B2 (en)2006-06-202016-09-27Ebr Systems, Inc.Systems and methods for implantable leadless tissue stimulation
US9492669B2 (en)2014-11-112016-11-15Medtronic, Inc.Mode switching by a ventricular leadless pacing device
US9492668B2 (en)2014-11-112016-11-15Medtronic, Inc.Mode switching by a ventricular leadless pacing device
US9511236B2 (en)2011-11-042016-12-06Pacesetter, Inc.Leadless cardiac pacemaker with integral battery and redundant welds
US9577864B2 (en)2013-09-242017-02-21Proteus Digital Health, Inc.Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US9597487B2 (en)2010-04-072017-03-21Proteus Digital Health, Inc.Miniature ingestible device
US9603550B2 (en)2008-07-082017-03-28Proteus Digital Health, Inc.State characterization based on multi-variate data fusion techniques
US9623234B2 (en)2014-11-112017-04-18Medtronic, Inc.Leadless pacing device implantation
US9659423B2 (en)2008-12-152017-05-23Proteus Digital Health, Inc.Personal authentication apparatus system and method
US9724519B2 (en)2014-11-112017-08-08Medtronic, Inc.Ventricular leadless pacing device mode switching
US9731139B2 (en)2008-07-162017-08-15Ebr Systems, Inc.Local lead to improve energy efficiency in implantable wireless acoustic stimulators
US9756874B2 (en)2011-07-112017-09-12Proteus Digital Health, Inc.Masticable ingestible product and communication system therefor
US9775991B1 (en)2011-10-112017-10-03A-Hamid HakkiEndovascular electrode system for tissue stimulation with embedded generator
US9796576B2 (en)2013-08-302017-10-24Proteus Digital Health, Inc.Container with electronically controlled interlock
US9802054B2 (en)2012-08-012017-10-31Pacesetter, Inc.Biostimulator circuit with flying cell
US9883819B2 (en)2009-01-062018-02-06Proteus Digital Health, Inc.Ingestion-related biofeedback and personalized medical therapy method and system
US10084880B2 (en)2013-11-042018-09-25Proteus Digital Health, Inc.Social media networking based on physiologic information
US10118054B2 (en)2016-07-072018-11-06The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing physiological conditions
US10175376B2 (en)2013-03-152019-01-08Proteus Digital Health, Inc.Metal detector apparatus, system, and method
US10187121B2 (en)2016-07-222019-01-22Proteus Digital Health, Inc.Electromagnetic sensing and detection of ingestible event markers
US10223905B2 (en)2011-07-212019-03-05Proteus Digital Health, Inc.Mobile device and system for detection and communication of information received from an ingestible device
US10390720B2 (en)2014-07-172019-08-27Medtronic, Inc.Leadless pacing system including sensing extension
US10398161B2 (en)2014-01-212019-09-03Proteus Digital Heal Th, Inc.Masticable ingestible product and communication system therefor
US10500394B1 (en)*2011-10-112019-12-10A-Hamid HakkiPacemaker system equipped with a flexible intercostal generator
US10529044B2 (en)2010-05-192020-01-07Proteus Digital Health, Inc.Tracking and delivery confirmation of pharmaceutical products
US10675476B2 (en)2016-12-222020-06-09Cardiac Pacemakers, Inc.Internal thoracic vein placement of a transmitter electrode for leadless stimulation of the heart
US11051543B2 (en)2015-07-212021-07-06Otsuka Pharmaceutical Co. Ltd.Alginate on adhesive bilayer laminate film
US11103710B2 (en)2018-06-032021-08-31Olga BOCKERIASystems, methods, and devices for treating bradyarrhythmias, tachyarrhythmias and heart failure
US11149123B2 (en)2013-01-292021-10-19Otsuka Pharmaceutical Co., Ltd.Highly-swellable polymeric films and compositions comprising the same
US11158149B2 (en)2013-03-152021-10-26Otsuka Pharmaceutical Co., Ltd.Personal authentication apparatus system and method
US11207527B2 (en)2016-07-062021-12-28Cardiac Pacemakers, Inc.Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US11529071B2 (en)2016-10-262022-12-20Otsuka Pharmaceutical Co., Ltd.Methods for manufacturing capsules with ingestible event markers
US11612321B2 (en)2007-11-272023-03-28Otsuka Pharmaceutical Co., Ltd.Transbody communication systems employing communication channels
US11654287B2 (en)2019-08-302023-05-23Ebr Systems, Inc.Pulse delivery device including slew rate detector, and associated systems and methods
US11744481B2 (en)2013-03-152023-09-05Otsuka Pharmaceutical Co., Ltd.System, apparatus and methods for data collection and assessing outcomes
US12023488B2 (en)2020-08-172024-07-02Ebr Systems, Inc.Implantable stimulation assemblies having tissue engagement mechanisms, and associated systems and methods
US12218518B2 (en)2023-04-142025-02-04Ultrapower, Inc.System and method for powering an implantable device using acoustic energy
US12350497B2 (en)2022-02-102025-07-08Ebr Systems, Inc.Tissue stimulation systems and methods, such as for pacing cardiac tissue

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US7283874B2 (en)*2000-10-162007-10-16Remon Medical Technologies Ltd.Acoustically powered implantable stimulating device
US10390714B2 (en)2005-01-122019-08-27Remon Medical Technologies, Ltd.Devices for fixing a sensor in a lumen
US8634908B2 (en)2005-08-012014-01-21Ebr Systems, Inc.Efficiently delivering acoustic stimulation energy to tissue
US8676349B2 (en)2006-09-152014-03-18Cardiac Pacemakers, Inc.Mechanism for releasably engaging an implantable medical device for implantation
US8593107B2 (en)2008-10-272013-11-26Cardiac Pacemakers, Inc.Methods and systems for recharging an implanted device by delivering a section of a charging device adjacent the implanted device within a body

Citations (45)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3456134A (en)*1967-10-051969-07-15Us Health Education & WelfarePiezoelectric energy converter for electronic implants
US3552382A (en)*1968-01-111971-01-05Hoffmann La RocheUltrasonic transducer assembly for biological inspections
US3659615A (en)*1970-06-081972-05-02Carl C EngerEncapsulated non-permeable piezoelectric powered pacesetter
US3835864A (en)*1970-09-211974-09-17Rasor Ass IncIntra-cardiac stimulator
US3867950A (en)*1971-06-181975-02-25Univ Johns HopkinsFixed rate rechargeable cardiac pacemaker
US4481950A (en)1979-04-271984-11-13Medtronic, Inc.Acoustic signalling apparatus for implantable devices
US4561444A (en)*1981-08-101985-12-31Cordis CorporationImplantable cardiac pacer having dual frequency programming and bipolar/linipolar lead programmability
US4600017A (en)1984-07-191986-07-15Cordis CorporationPacing lead with sensor
US4690143A (en)*1984-07-191987-09-01Cordis CorporationPacing lead with piezoelectric power generating means
US4706681A (en)1984-07-261987-11-17Telectronics N.V.Cardiac ultrasonically marked leads and method for used same
US4770177A (en)1986-02-181988-09-13Telectronics N.V.Apparatus and method for adjusting heart/pacer relative to changes in venous diameter during exercise to obtain a required cardiac output.
US4886064A (en)*1987-11-251989-12-12Siemens AktiengesellschaftBody activity controlled heart pacer
US4896068A (en)*1986-09-301990-01-23Siemens AktiengesellschaftActivity sensor for a heart pacemaker
US4945898A (en)1989-07-121990-08-07Diasonics, Inc.Power supply
US5065761A (en)1989-07-121991-11-19Diasonics, Inc.Lithotripsy system
US5113859A (en)1988-09-191992-05-19Medtronic, Inc.Acoustic body bus medical device communication system
US5139020A (en)1991-03-081992-08-18Telectronics Pacing Systems, Inc.Method and apparatus for controlling the hemodynamic state of a patient based on systolic time interval measurements detecting using doppler ultrasound techniques
US5156154A (en)1991-03-081992-10-20Telectronics Pacing Systems, Inc.Monitoring the hemodynamic state of a patient from measurements of myocardial contractility using doppler ultrasound techniques
US5156148A (en)1987-10-061992-10-20Leonard BloomSystem for treating a malfunctioning heart
US5156157A (en)1991-03-081992-10-20Telectronics Pacing Systems, Inc.Catheter-mounted doppler ultrasound transducer and signal processor
US5158071A (en)1988-07-011992-10-27Hitachi, Ltd.Ultrasonic apparatus for therapeutical use
US5183040A (en)1991-03-081993-02-02Telectronics Pacing Systems, Inc.Apparatus and method for detecting abnormal cardiac rhythms using an ultrasound sensor in an arrhythmia control system
US5188106A (en)1991-03-081993-02-23Telectronics Pacing Systems, Inc.Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasound
US5243976A (en)1990-09-111993-09-14Ferek Petric BozidarTricuspid flow synchronized cardiac electrotherapy system with blood flow measurement transducer and controlled pacing signals based on blood flow measurement
US5271408A (en)1991-03-251993-12-21Siemens Elema AbHydrodynamic system for blood flow measurement
US5311095A (en)1992-05-141994-05-10Duke UniversityUltrasonic transducer array
US5318595A (en)1989-09-251994-06-07Ferek Petric BozidarPacing method and system for blood flow velocity measurement and regulation of heart stimulating signals based on blood flow velocity
US5329496A (en)1992-10-161994-07-12Duke UniversityTwo-dimensional array ultrasonic transducers
US5330505A (en)1992-05-081994-07-19Leonard BloomSystem for and method of treating a malfunctioning heart
US5409009A (en)1994-03-181995-04-25Medtronic, Inc.Methods for measurement of arterial blood flow
US5411535A (en)1992-03-031995-05-02Terumo Kabushiki KaishaCardiac pacemaker using wireless transmission
US5674258A (en)1995-03-081997-10-07Medtronic, Inc.Packaged integrated accelerometer
US5744898A (en)1992-05-141998-04-28Duke UniversityUltrasound transducer array with transmitter/receiver integrated circuitry
US5749909A (en)1996-11-071998-05-12Sulzer Intermedics Inc.Transcutaneous energy coupling using piezoelectric device
US5799350A (en)1994-03-301998-09-01Pacesetter AbBlood flow velocity measurement device
US5807258A (en)1997-10-141998-09-15Cimochowski; George E.Ultrasonic sensors for monitoring the condition of a vascular graft
US5814089A (en)1996-12-181998-09-29Medtronic, Inc.Leadless multisite implantable stimulus and diagnostic system
US5861018A (en)*1996-05-281999-01-19Telecom Medical Inc.Ultrasound transdermal communication system and method
US5911738A (en)1997-07-311999-06-15Medtronic, Inc.High output sensor and accelerometer implantable medical device
US5967986A (en)1997-11-251999-10-19Vascusense, Inc.Endoluminal implant with fluid flow sensing capability
US5990598A (en)1997-09-231999-11-23Hewlett-Packard CompanySegment connections for multiple elevation transducers
US6020675A (en)1995-09-132000-02-01Kabushiki Kaisha ToshibaUltrasonic probe
US6141588A (en)1998-07-242000-10-31Intermedics Inc.Cardiac simulation system having multiple stimulators for anti-arrhythmia therapy
US6216040B1 (en)*1998-08-312001-04-10Advanced Bionics CorporationImplantable microphone system for use with cochlear implantable hearing aids
US6259951B1 (en)*1999-05-142001-07-10Advanced Bionics CorporationImplantable cochlear stimulator system incorporating combination electrode/transducer

Patent Citations (51)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3456134A (en)*1967-10-051969-07-15Us Health Education & WelfarePiezoelectric energy converter for electronic implants
US3552382A (en)*1968-01-111971-01-05Hoffmann La RocheUltrasonic transducer assembly for biological inspections
US3659615A (en)*1970-06-081972-05-02Carl C EngerEncapsulated non-permeable piezoelectric powered pacesetter
US3835864A (en)*1970-09-211974-09-17Rasor Ass IncIntra-cardiac stimulator
US3867950A (en)*1971-06-181975-02-25Univ Johns HopkinsFixed rate rechargeable cardiac pacemaker
US4481950A (en)1979-04-271984-11-13Medtronic, Inc.Acoustic signalling apparatus for implantable devices
US4561444A (en)*1981-08-101985-12-31Cordis CorporationImplantable cardiac pacer having dual frequency programming and bipolar/linipolar lead programmability
US4600017A (en)1984-07-191986-07-15Cordis CorporationPacing lead with sensor
US4690143A (en)*1984-07-191987-09-01Cordis CorporationPacing lead with piezoelectric power generating means
US4706681A (en)1984-07-261987-11-17Telectronics N.V.Cardiac ultrasonically marked leads and method for used same
US4770177A (en)1986-02-181988-09-13Telectronics N.V.Apparatus and method for adjusting heart/pacer relative to changes in venous diameter during exercise to obtain a required cardiac output.
US4896068A (en)*1986-09-301990-01-23Siemens AktiengesellschaftActivity sensor for a heart pacemaker
US5156148A (en)1987-10-061992-10-20Leonard BloomSystem for treating a malfunctioning heart
US4886064A (en)*1987-11-251989-12-12Siemens AktiengesellschaftBody activity controlled heart pacer
US5158071A (en)1988-07-011992-10-27Hitachi, Ltd.Ultrasonic apparatus for therapeutical use
US5113859A (en)1988-09-191992-05-19Medtronic, Inc.Acoustic body bus medical device communication system
US5065761A (en)1989-07-121991-11-19Diasonics, Inc.Lithotripsy system
US4945898A (en)1989-07-121990-08-07Diasonics, Inc.Power supply
US5409002A (en)1989-07-121995-04-25Focus Surgery IncorporatedTreatment system with localization
US5318595A (en)1989-09-251994-06-07Ferek Petric BozidarPacing method and system for blood flow velocity measurement and regulation of heart stimulating signals based on blood flow velocity
US5243976A (en)1990-09-111993-09-14Ferek Petric BozidarTricuspid flow synchronized cardiac electrotherapy system with blood flow measurement transducer and controlled pacing signals based on blood flow measurement
US5316001A (en)1990-09-111994-05-31Ferek Petric BozidarCardiac measurement system for measuring blood flow velocity by use of a sensor implanted inside the heart
US5139020A (en)1991-03-081992-08-18Telectronics Pacing Systems, Inc.Method and apparatus for controlling the hemodynamic state of a patient based on systolic time interval measurements detecting using doppler ultrasound techniques
US5156154A (en)1991-03-081992-10-20Telectronics Pacing Systems, Inc.Monitoring the hemodynamic state of a patient from measurements of myocardial contractility using doppler ultrasound techniques
US5156157A (en)1991-03-081992-10-20Telectronics Pacing Systems, Inc.Catheter-mounted doppler ultrasound transducer and signal processor
US5183040A (en)1991-03-081993-02-02Telectronics Pacing Systems, Inc.Apparatus and method for detecting abnormal cardiac rhythms using an ultrasound sensor in an arrhythmia control system
US5188106A (en)1991-03-081993-02-23Telectronics Pacing Systems, Inc.Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasound
US5271408A (en)1991-03-251993-12-21Siemens Elema AbHydrodynamic system for blood flow measurement
US5411535A (en)1992-03-031995-05-02Terumo Kabushiki KaishaCardiac pacemaker using wireless transmission
US5330505A (en)1992-05-081994-07-19Leonard BloomSystem for and method of treating a malfunctioning heart
US5311095A (en)1992-05-141994-05-10Duke UniversityUltrasonic transducer array
US5744898A (en)1992-05-141998-04-28Duke UniversityUltrasound transducer array with transmitter/receiver integrated circuitry
US5548564A (en)1992-10-161996-08-20Duke UniversityMulti-layer composite ultrasonic transducer arrays
US5329496A (en)1992-10-161994-07-12Duke UniversityTwo-dimensional array ultrasonic transducers
US5409009A (en)1994-03-181995-04-25Medtronic, Inc.Methods for measurement of arterial blood flow
US5799350A (en)1994-03-301998-09-01Pacesetter AbBlood flow velocity measurement device
US5885471A (en)1995-03-081999-03-23Medtronic, Inc.Shock resistant accelerometer for implantable medical device
US5674258A (en)1995-03-081997-10-07Medtronic, Inc.Packaged integrated accelerometer
US6038475A (en)1995-03-082000-03-14Medtronic, Inc.High output sensor and accelerometer for implantable medical device
US6020675A (en)1995-09-132000-02-01Kabushiki Kaisha ToshibaUltrasonic probe
US5861018A (en)*1996-05-281999-01-19Telecom Medical Inc.Ultrasound transdermal communication system and method
US5749909A (en)1996-11-071998-05-12Sulzer Intermedics Inc.Transcutaneous energy coupling using piezoelectric device
US5814089A (en)1996-12-181998-09-29Medtronic, Inc.Leadless multisite implantable stimulus and diagnostic system
US5911738A (en)1997-07-311999-06-15Medtronic, Inc.High output sensor and accelerometer implantable medical device
US5990598A (en)1997-09-231999-11-23Hewlett-Packard CompanySegment connections for multiple elevation transducers
US5807258A (en)1997-10-141998-09-15Cimochowski; George E.Ultrasonic sensors for monitoring the condition of a vascular graft
US5967989A (en)1997-10-141999-10-19Vascusense, Inc.Ultrasonic sensors for monitoring the condition of a vascular graft
US5967986A (en)1997-11-251999-10-19Vascusense, Inc.Endoluminal implant with fluid flow sensing capability
US6141588A (en)1998-07-242000-10-31Intermedics Inc.Cardiac simulation system having multiple stimulators for anti-arrhythmia therapy
US6216040B1 (en)*1998-08-312001-04-10Advanced Bionics CorporationImplantable microphone system for use with cochlear implantable hearing aids
US6259951B1 (en)*1999-05-142001-07-10Advanced Bionics CorporationImplantable cochlear stimulator system incorporating combination electrode/transducer

Cited By (314)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US7948148B2 (en)1997-12-302011-05-24Remon Medical Technologies Ltd.Piezoelectric transducer
US8647328B2 (en)1997-12-302014-02-11Remon Medical Technologies, Ltd.Reflected acoustic wave modulation
US7621905B2 (en)1997-12-302009-11-24Remon Medical Technologies Ltd.Devices for intrabody delivery of molecules and systems and methods utilizing same
US8277441B2 (en)1997-12-302012-10-02Remon Medical Technologies, Ltd.Piezoelectric transducer
US7641619B2 (en)2000-10-162010-01-05Remon Medical Technologies, Ltd.Barometric pressure correction based on remote sources of information
US8603086B2 (en)*2002-02-112013-12-10Gold-T Tech, Inc.Method for preventing thrombus formation
US20050222622A1 (en)*2002-02-112005-10-06Gold-T Tech, Inc.Method for preventing thrombus formation
US9457196B2 (en)2002-08-192016-10-04Arizona Board Of Regents On Behalf Of Arizona State UniversityNeurostimulator
US9555258B2 (en)2002-08-192017-01-31Arizona Board Of Regents On Behalf Of Arizona State UnveristyNeurostimulator
US20130096656A1 (en)*2002-08-192013-04-18Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf Of Arizona State UniversityNeurostimulator
US8626303B2 (en)*2002-08-192014-01-07Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf Of Arizona State UniversityNeurostimulator
US10016612B2 (en)2002-08-192018-07-10Arizona Board Of Regents On Behalf Of Arizona State UniversityNeurostimulator
US8774928B2 (en)*2002-08-192014-07-08Arizona Board of Regents on Behalf Arizona State UniversityNeurostimulator
US20110077722A1 (en)*2002-08-192011-03-31Arizona Board of Regents, a body corporate acting and on behalf of Arizona State UniversityNeurostimulator
US20070142728A1 (en)*2003-04-142007-06-21Avi PennerApparatus and methods using acoustic telemetry for intrabody communications
US8540631B2 (en)2003-04-142013-09-24Remon Medical Technologies, Ltd.Apparatus and methods using acoustic telemetry for intrabody communications
US9333364B2 (en)2004-06-152016-05-10Ebr Systems, Inc.Methods and systems for heart failure treatments using ultrasound and leadless implantable devices
US8852099B2 (en)2004-09-172014-10-07Cardiac Pacemakers, Inc.Systems and methods for deriving relative physiologic measurements
US8271093B2 (en)2004-09-172012-09-18Cardiac Pacemakers, Inc.Systems and methods for deriving relative physiologic measurements using a backend computing system
US20100106011A1 (en)*2004-11-232010-04-29Charles Bryan ByrdMethod and apparatus for localizing an ultrasound catheter
US7713210B2 (en)2004-11-232010-05-11St. Jude Medical, Atrial Fibrillation Division, Inc.Method and apparatus for localizing an ultrasound catheter
US10639004B2 (en)2004-11-232020-05-05St. Jude Medical, Atrial Fibrillation Division, Inc.Method and apparatus for localizing an ultrasound catheter
US8428691B2 (en)2004-11-232013-04-23St. Jude Medical, Atrial Fibrillation Division, Inc.Method and apparatus for localizing an ultrasound catheter
US7580750B2 (en)2004-11-242009-08-25Remon Medical Technologies, Ltd.Implantable medical device with integrated acoustic transducer
US8744580B2 (en)2004-11-242014-06-03Remon Medical Technologies, Ltd.Implantable medical device with integrated acoustic transducer
US7813808B1 (en)2004-11-242010-10-12Remon Medical Technologies LtdImplanted sensor system with optimized operational and sensing parameters
US7522962B1 (en)2004-12-032009-04-21Remon Medical Technologies, LtdImplantable medical device with integrated acoustic transducer
US20070078490A1 (en)*2004-12-212007-04-05Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US7848815B2 (en)2004-12-212010-12-07Ebr Systems, Inc.Implantable transducer devices
US7610092B2 (en)2004-12-212009-10-27Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US20060136005A1 (en)*2004-12-212006-06-22Ebr Systems, Inc.Implantable transducer devices
US9008776B2 (en)2004-12-212015-04-14Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US7558631B2 (en)2004-12-212009-07-07Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US8315701B2 (en)2004-12-212012-11-20Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US7890173B2 (en)2004-12-212011-02-15Ebr Systems, Inc.Implantable transducer devices
US20090326601A1 (en)*2004-12-212009-12-31Ebr Systems, Inc.Implantable transducer devices
US20060136004A1 (en)*2004-12-212006-06-22Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US7606621B2 (en)2004-12-212009-10-20Ebr Systems, Inc.Implantable transducer devices
US7996087B2 (en)2004-12-212011-08-09Ebr Systems, Inc.Leadless tissue stimulation systems and methods
US20060217767A1 (en)*2005-03-242006-09-28Kenergy, Inc.Implantable medical stimulation apparatus with intra-conductor capacitive energy storage
US7310556B2 (en)*2005-03-242007-12-18Kenergy, Inc.Implantable medical stimulation apparatus with intra-conductor capacitive energy storage
US8847766B2 (en)2005-04-282014-09-30Proteus Digital Health, Inc.Pharma-informatics system
US10517507B2 (en)2005-04-282019-12-31Proteus Digital Health, Inc.Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en)2005-04-282014-12-16Proteus Digital Health, Inc.Communication system with remote activation
US9962107B2 (en)2005-04-282018-05-08Proteus Digital Health, Inc.Communication system with enhanced partial power source and method of manufacturing same
US8674825B2 (en)2005-04-282014-03-18Proteus Digital Health, Inc.Pharma-informatics system
US8730031B2 (en)2005-04-282014-05-20Proteus Digital Health, Inc.Communication system using an implantable device
US9198608B2 (en)2005-04-282015-12-01Proteus Digital Health, Inc.Communication system incorporated in a container
US10610128B2 (en)2005-04-282020-04-07Proteus Digital Health, Inc.Pharma-informatics system
US10542909B2 (en)2005-04-282020-01-28Proteus Digital Health, Inc.Communication system with partial power source
US9681842B2 (en)2005-04-282017-06-20Proteus Digital Health, Inc.Pharma-informatics system
US9649066B2 (en)2005-04-282017-05-16Proteus Digital Health, Inc.Communication system with partial power source
US9439582B2 (en)2005-04-282016-09-13Proteus Digital Health, Inc.Communication system with remote activation
US9597010B2 (en)2005-04-282017-03-21Proteus Digital Health, Inc.Communication system using an implantable device
US11476952B2 (en)2005-04-282022-10-18Otsuka Pharmaceutical Co., Ltd.Pharma-informatics system
US7978064B2 (en)2005-04-282011-07-12Proteus Biomedical, Inc.Communication system with partial power source
US9161707B2 (en)2005-04-282015-10-20Proteus Digital Health, Inc.Communication system incorporated in an ingestible product
US8802183B2 (en)2005-04-282014-08-12Proteus Digital Health, Inc.Communication system with enhanced partial power source and method of manufacturing same
US8816847B2 (en)2005-04-282014-08-26Proteus Digital Health, Inc.Communication system with partial power source
US9119554B2 (en)2005-04-282015-09-01Proteus Digital Health, Inc.Pharma-informatics system
US20060253193A1 (en)*2005-05-032006-11-09Lichtenstein Samuel VMechanical means for controlling blood pressure
US7615012B2 (en)2005-08-262009-11-10Cardiac Pacemakers, Inc.Broadband acoustic sensor for an implantable medical device
US7570998B2 (en)*2005-08-262009-08-04Cardiac Pacemakers, Inc.Acoustic communication transducer in implantable medical device header
US11376439B2 (en)2005-08-312022-07-05Ebr Systems, Inc.Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
US10207115B2 (en)2005-08-312019-02-19Ebr Systems, Inc.Method and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
US7765001B2 (en)2005-08-312010-07-27Ebr Systems, Inc.Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
US12133983B2 (en)2005-08-312024-11-05Ebr Systems, Inc.Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
WO2007027940A3 (en)*2005-08-312007-06-28Ebr Systems IncMethods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
US8547248B2 (en)2005-09-012013-10-01Proteus Digital Health, Inc.Implantable zero-wire communications system
US7742815B2 (en)2005-09-092010-06-22Cardiac Pacemakers, Inc.Using implanted sensors for feedback control of implanted medical devices
US7949394B2 (en)2005-09-092011-05-24Cardiac Pacemakers, Inc.Using implanted sensors for feedback control of implanted medical devices
US7702392B2 (en)2005-09-122010-04-20Ebr Systems, Inc.Methods and apparatus for determining cardiac stimulation sites using hemodynamic data
US20070060961A1 (en)*2005-09-122007-03-15Ebr Systems, Inc.Methods and apparatus for determining cardiac stimulation sites using hemodynamic data
US9192774B2 (en)2005-10-142015-11-24Pacesetter, Inc.Cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US8352025B2 (en)2005-10-142013-01-08Nanostim, Inc.Leadless cardiac pacemaker triggered by conductive communication
US9409033B2 (en)2005-10-142016-08-09Pacesetter, Inc.Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US8788035B2 (en)2005-10-142014-07-22Pacesetter, Inc.Leadless cardiac pacemaker triggered by conductive communication
US7937148B2 (en)2005-10-142011-05-03Nanostim, Inc.Rate responsive leadless cardiac pacemaker
US8295939B2 (en)2005-10-142012-10-23Nanostim, Inc.Programmer for biostimulator system
US9168383B2 (en)2005-10-142015-10-27Pacesetter, Inc.Leadless cardiac pacemaker with conducted communication
US9358400B2 (en)2005-10-142016-06-07Pacesetter, Inc.Leadless cardiac pacemaker
US9687666B2 (en)2005-10-142017-06-27Pacesetter, Inc.Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US7945333B2 (en)2005-10-142011-05-17Nanostim, Inc.Programmer for biostimulator system
US8788053B2 (en)2005-10-142014-07-22Pacesetter, Inc.Programmer for biostimulator system
US9216298B2 (en)2005-10-142015-12-22Pacesetter, Inc.Leadless cardiac pacemaker system with conductive communication
US9072913B2 (en)2005-10-142015-07-07Pacesetter, Inc.Rate responsive leadless cardiac pacemaker
US9872999B2 (en)2005-10-142018-01-23Pacesetter, Inc.Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US10238883B2 (en)2005-10-142019-03-26Pacesetter Inc.Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US8855789B2 (en)2005-10-142014-10-07Pacesetter, Inc.Implantable biostimulator delivery system
US8798745B2 (en)2005-10-142014-08-05Pacesetter, Inc.Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US8457742B2 (en)2005-10-142013-06-04Nanostim, Inc.Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator
US8010209B2 (en)2005-10-142011-08-30Nanostim, Inc.Delivery system for implantable biostimulator
US9227077B2 (en)2005-10-142016-01-05Pacesetter, Inc.Leadless cardiac pacemaker triggered by conductive communication
US9155479B2 (en)2005-12-122015-10-13Tor PetersIntra cardiac device, system and methods
US9814896B2 (en)2005-12-122017-11-14Tor PetersIntra cardiac device, system and methods
US20090171408A1 (en)*2005-12-122009-07-02Jan Otto SolemIntra Cardiac Device, System And Methods
US8836513B2 (en)2006-04-282014-09-16Proteus Digital Health, Inc.Communication system incorporated in an ingestible product
US8956287B2 (en)2006-05-022015-02-17Proteus Digital Health, Inc.Patient customized therapeutic regimens
US11928614B2 (en)2006-05-022024-03-12Otsuka Pharmaceutical Co., Ltd.Patient customized therapeutic regimens
US20070276444A1 (en)*2006-05-242007-11-29Daniel GelbartSelf-powered leadless pacemaker
US8838244B2 (en)2006-06-022014-09-16Semiconductor Energy Laboratory Co., Ltd.Cardiac pacemaker device with circuits for monitoring residual capacity of battery
US20070282383A1 (en)*2006-06-022007-12-06Semiconductor Energy Laboratory Co., Ltd.Cardiac pacemaker device
US10143850B2 (en)2006-06-202018-12-04Ebr Systems, Inc.Systems and methods for implantable leadless tissue stimulation
US20070293904A1 (en)*2006-06-202007-12-20Daniel GelbartSelf-powered resonant leadless pacemaker
US9452286B2 (en)2006-06-202016-09-27Ebr Systems, Inc.Systems and methods for implantable leadless tissue stimulation
WO2008011570A1 (en)*2006-07-212008-01-24Cardiac Pacemakers, Inc.Acoustic communication transducer in implantable medical device header
US20080021972A1 (en)*2006-07-212008-01-24Cardiac Pacemakers, Inc.System and method for addressing implantable devices
AU2007275231B2 (en)*2006-07-212010-09-02Cardiac Pacemakers, Inc.Acoustic communication transducer in implantable medical device header
US7955268B2 (en)2006-07-212011-06-07Cardiac Pacemakers, Inc.Multiple sensor deployment
JP2009544365A (en)*2006-07-212009-12-17カーディアック ペースメイカーズ, インコーポレイテッド Ultrasonic transmitting / receiving transducer housed in header of implantable medical device
US7949396B2 (en)2006-07-212011-05-24Cardiac Pacemakers, Inc.Ultrasonic transducer for a metallic cavity implated medical device
US8548592B2 (en)2006-07-212013-10-01Cardiac Pacemakers, Inc.Ultrasonic transducer for a metallic cavity implanted medical device
US7908334B2 (en)2006-07-212011-03-15Cardiac Pacemakers, Inc.System and method for addressing implantable devices
US7912548B2 (en)2006-07-212011-03-22Cardiac Pacemakers, Inc.Resonant structures for implantable devices
US8054140B2 (en)2006-10-172011-11-08Proteus Biomedical, Inc.Low voltage oscillator for medical devices
US8945005B2 (en)2006-10-252015-02-03Proteus Digital Health, Inc.Controlled activation ingestible identifier
US10238604B2 (en)2006-10-252019-03-26Proteus Digital Health, Inc.Controlled activation ingestible identifier
US11357730B2 (en)2006-10-252022-06-14Otsuka Pharmaceutical Co., Ltd.Controlled activation ingestible identifier
US8718193B2 (en)2006-11-202014-05-06Proteus Digital Health, Inc.Active signal processing personal health signal receivers
US9444503B2 (en)2006-11-202016-09-13Proteus Digital Health, Inc.Active signal processing personal health signal receivers
US9083589B2 (en)2006-11-202015-07-14Proteus Digital Health, Inc.Active signal processing personal health signal receivers
US10441194B2 (en)2007-02-012019-10-15Proteus Digital Heal Th, Inc.Ingestible event marker systems
US8858432B2 (en)2007-02-012014-10-14Proteus Digital Health, Inc.Ingestible event marker systems
US8956288B2 (en)2007-02-142015-02-17Proteus Digital Health, Inc.In-body power source having high surface area electrode
US11464423B2 (en)2007-02-142022-10-11Otsuka Pharmaceutical Co., Ltd.In-body power source having high surface area electrode
US9270025B2 (en)2007-03-092016-02-23Proteus Digital Health, Inc.In-body device having deployable antenna
US8932221B2 (en)2007-03-092015-01-13Proteus Digital Health, Inc.In-body device having a multi-directional transmitter
WO2008112577A1 (en)*2007-03-092008-09-18Proteus Biomedical, Inc.In-body device having a multi-directional transmitter
US8798770B2 (en)2007-05-172014-08-05Cardiac Pacemakers, Inc.Systems and methods for fixating transvenously implanted medical devices
US20080288039A1 (en)*2007-05-172008-11-20Cardiac Pacemakers, Inc.Systems and methods for fixating transvenously implanted medical devices
US8825161B1 (en)2007-05-172014-09-02Cardiac Pacemakers, Inc.Acoustic transducer for an implantable medical device
US9827426B2 (en)2007-05-172017-11-28Cardiac Pacemakers, Inc.Systems and methods for fixating transvenously implanted medical devices
US8103359B2 (en)2007-05-172012-01-24Cardiac Pacemakers, Inc.Systems and methods for fixating transvenously implanted medical devices
US10080903B2 (en)2007-05-232018-09-25Ebr Systems, Inc.Optimizing energy transmission in a leadless tissue stimulation system
US20080294208A1 (en)*2007-05-232008-11-27Ebr Systems, Inc.Optimizing energy transmission in a leadless tissue stimulation system
US8718773B2 (en)2007-05-232014-05-06Ebr Systems, Inc.Optimizing energy transmission in a leadless tissue stimulation system
US10456588B2 (en)2007-05-232019-10-29Ebr Systems, Inc.Optimizing energy transmission in a leadless tissue stimulation system
US11452879B2 (en)2007-05-232022-09-27Ebr Systems, Inc.Optimizing energy transmission in a leadless tissue stimulation system
US8540632B2 (en)2007-05-242013-09-24Proteus Digital Health, Inc.Low profile antenna for in body device
US8115618B2 (en)2007-05-242012-02-14Proteus Biomedical, Inc.RFID antenna for in-body device
US10517506B2 (en)2007-05-242019-12-31Proteus Digital Health, Inc.Low profile antenna for in body device
US8340778B2 (en)2007-06-142012-12-25Cardiac Pacemakers, Inc.Multi-element acoustic recharging system
US7634318B2 (en)2007-06-142009-12-15Cardiac Pacemakers, Inc.Multi-element acoustic recharging system
US9731141B2 (en)2007-06-142017-08-15Cardiac Pacemakers, Inc.Multi-element acoustic recharging system
US8082041B1 (en)*2007-06-152011-12-20Piezo Energy Technologies, LLCBio-implantable ultrasound energy capture and storage assembly including transmitter and receiver cooling
US8961412B2 (en)2007-09-252015-02-24Proteus Digital Health, Inc.In-body device with virtual dipole signal amplification
US9433371B2 (en)2007-09-252016-09-06Proteus Digital Health, Inc.In-body device with virtual dipole signal amplification
US11612321B2 (en)2007-11-272023-03-28Otsuka Pharmaceutical Co., Ltd.Transbody communication systems employing communication channels
US7953493B2 (en)2007-12-272011-05-31Ebr Systems, Inc.Optimizing size of implantable medical devices by isolating the power source
US8041431B2 (en)2008-01-072011-10-18Cardiac Pacemakers, Inc.System and method for in situ trimming of oscillators in a pair of implantable medical devices
US20090177251A1 (en)*2008-01-072009-07-09Paul HuelskampSystem And Method For In Situ Trimming Of Oscillators In A Pair Of Implantable Medical Devices
US20090198307A1 (en)*2008-02-062009-08-06Bin MiDirect inductive/acoustic converter for implantable medical device
US8301262B2 (en)2008-02-062012-10-30Cardiac Pacemakers, Inc.Direct inductive/acoustic converter for implantable medical device
US8725260B2 (en)2008-02-112014-05-13Cardiac Pacemakers, IncMethods of monitoring hemodynamic status for rhythm discrimination within the heart
US8369960B2 (en)2008-02-122013-02-05Cardiac Pacemakers, Inc.Systems and methods for controlling wireless signal transfers between ultrasound-enabled medical devices
US9258035B2 (en)2008-03-052016-02-09Proteus Digital Health, Inc.Multi-mode communication ingestible event markers and systems, and methods of using the same
US9060708B2 (en)2008-03-052015-06-23Proteus Digital Health, Inc.Multi-mode communication ingestible event markers and systems, and methods of using the same
US8258962B2 (en)2008-03-052012-09-04Proteus Biomedical, Inc.Multi-mode communication ingestible event markers and systems, and methods of using the same
US8810409B2 (en)2008-03-052014-08-19Proteus Digital Health, Inc.Multi-mode communication ingestible event markers and systems, and methods of using the same
US8542123B2 (en)2008-03-052013-09-24Proteus Digital Health, Inc.Multi-mode communication ingestible event markers and systems, and methods of using the same
US10688307B2 (en)2008-03-252020-06-23Ebr Systems, Inc.Temporary electrode connection for wireless pacing systems
US9283392B2 (en)2008-03-252016-03-15Ebr Systems, Inc.Temporary electrode connection for wireless pacing systems
US9180285B2 (en)2008-03-252015-11-10Ebr Systems, Inc.Implantable wireless accoustic stimulators with high energy conversion efficiencies
US9907968B2 (en)2008-03-252018-03-06Ebr Systems, Inc.Temporary electrode connection for wireless pacing systems
US9981138B2 (en)2008-03-252018-05-29Ebr Systems, Inc.Operation and estimation of output voltage of wireless stimulators
US11752352B2 (en)2008-03-252023-09-12Ebr Systems, Inc.Temporary electrode connection for wireless pacing systems
US20100234924A1 (en)*2008-03-252010-09-16Ebr Systems, Inc.Operation and estimation of output voltage of wireless stimulators
US8588926B2 (en)*2008-03-252013-11-19Ebr Systems, Inc.Implantable wireless accoustic stimulators with high energy conversion efficiencies
US10052493B2 (en)2008-03-252018-08-21Ebr Systems, Inc.Implantable wireless accoustic stimulators with high energy conversion efficiencies
US11712572B2 (en)2008-03-252023-08-01Ebr Systems, Inc.Implantable wireless acoustic stimulators with high energy conversion efficiencies
US8364276B2 (en)2008-03-252013-01-29Ebr Systems, Inc.Operation and estimation of output voltage of wireless stimulators
EP2452721A1 (en)2008-03-252012-05-16EBR Systems, Inc.Method of manufacturing implantable wireless acoustic stimulators with high energy conversion efficiencies
US10806938B2 (en)2008-03-252020-10-20Ebr Systems, Inc.Implantable wireless accoustic stimulators with high energy conversion efficiencies
WO2009120785A2 (en)2008-03-252009-10-01Ebr Systems, Inc.Implantable wireless acoustic stimulators with high energy conversion efficiencies
US9343654B2 (en)2008-03-252016-05-17Ebr Systems, Inc.Method of manufacturing implantable wireless acoustic stimulators with high energy conversion efficiencies
US10512785B2 (en)2008-03-252019-12-24Ebr Systems, Inc.Implantable wireless accoustic stimulators with high energy conversion efficiencies
DE102008016364A1 (en)*2008-03-292009-10-01Biotronik Crm Patent Ag Signal line of an implantable electromedical device
US9205250B2 (en)2008-03-292015-12-08Biotronik Crm Patent AgSignal line of an implantable electromedical configuration
US20090248102A1 (en)*2008-03-292009-10-01Ingo WeissSignal line of an implantable electromedical configuration
US8275459B2 (en)*2008-05-232012-09-25Biotronik Crm Patent AgWireless feedthrough for medical implants
US20100298909A1 (en)*2008-05-232010-11-25Ingo WeissWireless feedthrough for medical implants
EP2123325A2 (en)2008-05-232009-11-25BIOTRONIK CRM Patent AGWireless execution for medical implants
EP2123325A3 (en)*2008-05-232013-05-22Biotronik CRM Patent AGWireless execution for medical implants
US10682071B2 (en)2008-07-082020-06-16Proteus Digital Health, Inc.State characterization based on multi-variate data fusion techniques
US11217342B2 (en)2008-07-082022-01-04Otsuka Pharmaceutical Co., Ltd.Ingestible event marker data framework
US9603550B2 (en)2008-07-082017-03-28Proteus Digital Health, Inc.State characterization based on multi-variate data fusion techniques
US9731139B2 (en)2008-07-162017-08-15Ebr Systems, Inc.Local lead to improve energy efficiency in implantable wireless acoustic stimulators
US9415010B2 (en)2008-08-132016-08-16Proteus Digital Health, Inc.Ingestible circuitry
US8540633B2 (en)2008-08-132013-09-24Proteus Digital Health, Inc.Identifier circuits for generating unique identifiable indicators and techniques for producing same
US8721540B2 (en)2008-08-132014-05-13Proteus Digital Health, Inc.Ingestible circuitry
US8594802B2 (en)2008-08-142013-11-26Cardiac Pacemakers, Inc.Performance assessment and adaptation of an acoustic communication link
US8401662B2 (en)2008-08-142013-03-19Cardiac Pacemakers, Inc.Performance assessment and adaptation of an acoustic communication link
US8126566B2 (en)2008-08-142012-02-28Cardiac Pacemakers, Inc.Performance assessment and adaptation of an acoustic communication link
US20100042177A1 (en)*2008-08-142010-02-18Cardiac Pacemakers, Inc.Performance assessment and adaptation of an acoustic communication link
US8591423B2 (en)2008-10-102013-11-26Cardiac Pacemakers, Inc.Systems and methods for determining cardiac output using pulmonary artery pressure measurements
US8036748B2 (en)2008-11-132011-10-11Proteus Biomedical, Inc.Ingestible therapy activator system and method
US8632470B2 (en)2008-11-192014-01-21Cardiac Pacemakers, Inc.Assessment of pulmonary vascular resistance via pulmonary artery pressure
US8055334B2 (en)2008-12-112011-11-08Proteus Biomedical, Inc.Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8583227B2 (en)2008-12-112013-11-12Proteus Digital Health, Inc.Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8545436B2 (en)2008-12-152013-10-01Proteus Digital Health, Inc.Body-associated receiver and method
US9439566B2 (en)2008-12-152016-09-13Proteus Digital Health, Inc.Re-wearable wireless device
US9659423B2 (en)2008-12-152017-05-23Proteus Digital Health, Inc.Personal authentication apparatus system and method
US9149577B2 (en)2008-12-152015-10-06Proteus Digital Health, Inc.Body-associated receiver and method
US8114021B2 (en)2008-12-152012-02-14Proteus Biomedical, Inc.Body-associated receiver and method
WO2010070650A1 (en)2008-12-212010-06-24Sirius Implantable Systems Ltd.High efficiency piezoelectric micro-generator and energy storage system
US8597186B2 (en)2009-01-062013-12-03Proteus Digital Health, Inc.Pharmaceutical dosages delivery system
US9883819B2 (en)2009-01-062018-02-06Proteus Digital Health, Inc.Ingestion-related biofeedback and personalized medical therapy method and system
US9272155B2 (en)2009-02-022016-03-01Pacesetter, Inc.Leadless cardiac pacemaker with secondary fixation capability
US8527068B2 (en)2009-02-022013-09-03Nanostim, Inc.Leadless cardiac pacemaker with secondary fixation capability
USRE50564E1 (en)2009-02-022025-09-02Pacesetter, Inc.Leadless cardiac pacemaker with secondary fixation capability
US9119918B2 (en)2009-03-252015-09-01Proteus Digital Health, Inc.Probablistic pharmacokinetic and pharmacodynamic modeling
US8540664B2 (en)2009-03-252013-09-24Proteus Digital Health, Inc.Probablistic pharmacokinetic and pharmacodynamic modeling
US9320455B2 (en)2009-04-282016-04-26Proteus Digital Health, Inc.Highly reliable ingestible event markers and methods for using the same
US8545402B2 (en)2009-04-282013-10-01Proteus Digital Health, Inc.Highly reliable ingestible event markers and methods for using the same
US10588544B2 (en)2009-04-282020-03-17Proteus Digital Health, Inc.Highly reliable ingestible event markers and methods for using the same
US9149423B2 (en)2009-05-122015-10-06Proteus Digital Health, Inc.Ingestible event markers comprising an ingestible component
US8558563B2 (en)2009-08-212013-10-15Proteus Digital Health, Inc.Apparatus and method for measuring biochemical parameters
US10305544B2 (en)2009-11-042019-05-28Proteus Digital Health, Inc.System for supply chain management
US8868453B2 (en)2009-11-042014-10-21Proteus Digital Health, Inc.System for supply chain management
US9941931B2 (en)2009-11-042018-04-10Proteus Digital Health, Inc.System for supply chain management
US8784308B2 (en)2009-12-022014-07-22Proteus Digital Health, Inc.Integrated ingestible event marker system with pharmaceutical product
US9014779B2 (en)2010-02-012015-04-21Proteus Digital Health, Inc.Data gathering system
US10376218B2 (en)2010-02-012019-08-13Proteus Digital Health, Inc.Data gathering system
US11173290B2 (en)2010-04-072021-11-16Otsuka Pharmaceutical Co., Ltd.Miniature ingestible device
US9597487B2 (en)2010-04-072017-03-21Proteus Digital Health, Inc.Miniature ingestible device
US10207093B2 (en)2010-04-072019-02-19Proteus Digital Health, Inc.Miniature ingestible device
US8594806B2 (en)2010-04-302013-11-26Cyberonics, Inc.Recharging and communication lead for an implantable device
FR2960156A1 (en)*2010-05-192011-11-25Laurent BernemanImplantable electrode for use in cardiac pacemaker, has piezoelectric effect metal layer covered with thin film, where electrode is made of materials generating piezoelectric effect as primary or secondary energy source
US10529044B2 (en)2010-05-192020-01-07Proteus Digital Health, Inc.Tracking and delivery confirmation of pharmaceutical products
FR2982163A1 (en)*2010-05-192013-05-10Laurent Berneman MUSCULAR STIMULATION DEVICE, ESPECIALLY CARDIAC STIMULATOR, COMPRISING ELECTRODES OPERATING BY PIEZOELECTRIC EFFECT
US9687655B2 (en)2010-10-122017-06-27Pacesetter, Inc.Temperature sensor for a leadless cardiac pacemaker
US9060692B2 (en)2010-10-122015-06-23Pacesetter, Inc.Temperature sensor for a leadless cardiac pacemaker
US8543205B2 (en)2010-10-122013-09-24Nanostim, Inc.Temperature sensor for a leadless cardiac pacemaker
US9020611B2 (en)2010-10-132015-04-28Pacesetter, Inc.Leadless cardiac pacemaker with anti-unscrewing feature
US11504511B2 (en)2010-11-222022-11-22Otsuka Pharmaceutical Co., Ltd.Ingestible device with pharmaceutical product
US9107806B2 (en)2010-11-222015-08-18Proteus Digital Health, Inc.Ingestible device with pharmaceutical product
US8615310B2 (en)2010-12-132013-12-24Pacesetter, Inc.Delivery catheter systems and methods
US11890032B2 (en)2010-12-132024-02-06Pacesetter, Inc.Pacemaker retrieval systems and methods
US11786272B2 (en)2010-12-132023-10-17Pacesetter, Inc.Pacemaker retrieval systems and methods
US11759234B2 (en)2010-12-132023-09-19Pacesetter, Inc.Pacemaker retrieval systems and methods
US12226122B2 (en)2010-12-132025-02-18Pacesetter, Inc.Pacemaker retrieval systems and methods
US10188425B2 (en)2010-12-132019-01-29Pacesetter, Inc.Pacemaker retrieval systems and methods
US9126032B2 (en)2010-12-132015-09-08Pacesetter, Inc.Pacemaker retrieval systems and methods
US9242102B2 (en)2010-12-202016-01-26Pacesetter, Inc.Leadless pacemaker with radial fixation mechanism
US9439599B2 (en)2011-03-112016-09-13Proteus Digital Health, Inc.Wearable personal body associated device with various physical configurations
US9756874B2 (en)2011-07-112017-09-12Proteus Digital Health, Inc.Masticable ingestible product and communication system therefor
US11229378B2 (en)2011-07-112022-01-25Otsuka Pharmaceutical Co., Ltd.Communication system with enhanced partial power source and method of manufacturing same
US10223905B2 (en)2011-07-212019-03-05Proteus Digital Health, Inc.Mobile device and system for detection and communication of information received from an ingestible device
US9289593B1 (en)2011-10-112016-03-22A-Hamid HakkiEndovascular electrode system for tissue stimulation
US10500394B1 (en)*2011-10-112019-12-10A-Hamid HakkiPacemaker system equipped with a flexible intercostal generator
US9775991B1 (en)2011-10-112017-10-03A-Hamid HakkiEndovascular electrode system for tissue stimulation with embedded generator
US9216280B1 (en)2011-10-112015-12-22A-Hamid HakkiEndovascular electrode system for tissue stimulation
US9511236B2 (en)2011-11-042016-12-06Pacesetter, Inc.Leadless cardiac pacemaker with integral battery and redundant welds
US9235683B2 (en)2011-11-092016-01-12Proteus Digital Health, Inc.Apparatus, system, and method for managing adherence to a regimen
US20140277231A1 (en)*2011-11-242014-09-18Laurent BernemanMedical device involving muscle stimulation electrodes and an electromagnetic lead
US8974366B1 (en)2012-01-102015-03-10Piezo Energy Technologies, LLCHigh power ultrasound wireless transcutaneous energy transfer (US-TET) source
US9271897B2 (en)2012-07-232016-03-01Proteus Digital Health, Inc.Techniques for manufacturing ingestible event markers comprising an ingestible component
US10744332B2 (en)2012-08-012020-08-18Pacesetter, Inc.Biostimulator circuit with flying cell
US9802054B2 (en)2012-08-012017-10-31Pacesetter, Inc.Biostimulator circuit with flying cell
US9268909B2 (en)2012-10-182016-02-23Proteus Digital Health, Inc.Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US11149123B2 (en)2013-01-292021-10-19Otsuka Pharmaceutical Co., Ltd.Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en)2013-03-152019-01-08Proteus Digital Health, Inc.Metal detector apparatus, system, and method
US11741771B2 (en)2013-03-152023-08-29Otsuka Pharmaceutical Co., Ltd.Personal authentication apparatus system and method
US11744481B2 (en)2013-03-152023-09-05Otsuka Pharmaceutical Co., Ltd.System, apparatus and methods for data collection and assessing outcomes
US11158149B2 (en)2013-03-152021-10-26Otsuka Pharmaceutical Co., Ltd.Personal authentication apparatus system and method
US10421658B2 (en)2013-08-302019-09-24Proteus Digital Health, Inc.Container with electronically controlled interlock
US9796576B2 (en)2013-08-302017-10-24Proteus Digital Health, Inc.Container with electronically controlled interlock
US11102038B2 (en)2013-09-202021-08-24Otsuka Pharmaceutical Co., Ltd.Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US10097388B2 (en)2013-09-202018-10-09Proteus Digital Health, Inc.Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US10498572B2 (en)2013-09-202019-12-03Proteus Digital Health, Inc.Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9787511B2 (en)2013-09-202017-10-10Proteus Digital Health, Inc.Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9270503B2 (en)2013-09-202016-02-23Proteus Digital Health, Inc.Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9577864B2 (en)2013-09-242017-02-21Proteus Digital Health, Inc.Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en)2013-11-042018-09-25Proteus Digital Health, Inc.Social media networking based on physiologic information
US10398161B2 (en)2014-01-212019-09-03Proteus Digital Heal Th, Inc.Masticable ingestible product and communication system therefor
US11950615B2 (en)2014-01-212024-04-09Otsuka Pharmaceutical Co., Ltd.Masticable ingestible product and communication system therefor
US10390720B2 (en)2014-07-172019-08-27Medtronic, Inc.Leadless pacing system including sensing extension
US10674928B2 (en)2014-07-172020-06-09Medtronic, Inc.Leadless pacing system including sensing extension
US9399140B2 (en)2014-07-252016-07-26Medtronic, Inc.Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing
USRE48197E1 (en)2014-07-252020-09-08Medtronic, Inc.Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing
US10279168B2 (en)2014-11-112019-05-07Medtronic, Inc.Leadless pacing device implantation
US9724519B2 (en)2014-11-112017-08-08Medtronic, Inc.Ventricular leadless pacing device mode switching
US9623234B2 (en)2014-11-112017-04-18Medtronic, Inc.Leadless pacing device implantation
US9492668B2 (en)2014-11-112016-11-15Medtronic, Inc.Mode switching by a ventricular leadless pacing device
US9492669B2 (en)2014-11-112016-11-15Medtronic, Inc.Mode switching by a ventricular leadless pacing device
US9808628B2 (en)2014-11-112017-11-07Medtronic, Inc.Mode switching by a ventricular leadless pacing device
US9289612B1 (en)2014-12-112016-03-22Medtronic Inc.Coordination of ventricular pacing in a leadless pacing system
US11051543B2 (en)2015-07-212021-07-06Otsuka Pharmaceutical Co. Ltd.Alginate on adhesive bilayer laminate film
US11207527B2 (en)2016-07-062021-12-28Cardiac Pacemakers, Inc.Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10300310B2 (en)2016-07-072019-05-28The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing physiological conditions
US10898736B2 (en)2016-07-072021-01-26The Regents Of The University Of CaliforniaImplants using ultrasonic waves for stimulating tissue
US10682530B2 (en)2016-07-072020-06-16The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for detecting electrophysiological signals
US12268463B2 (en)2016-07-072025-04-08The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing electrical impedance of tissue
US12239408B2 (en)2016-07-072025-03-04The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing physiological conditions
US10576305B2 (en)2016-07-072020-03-03The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing physiological conditions
US11589748B2 (en)2016-07-072023-02-28The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing physiological conditions
US10300309B2 (en)2016-07-072019-05-28The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing physiological conditions
US11607128B2 (en)2016-07-072023-03-21The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing electrical impedance of tissue
US10744347B2 (en)2016-07-072020-08-18The Regents Of The University Of CaliforniaImplants using ultrasonic waves for stimulating tissue
US11786124B2 (en)2016-07-072023-10-17The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for radiation detection and oncology
US10118054B2 (en)2016-07-072018-11-06The Regents Of The University Of CaliforniaImplants using ultrasonic backscatter for sensing physiological conditions
US10765865B2 (en)2016-07-072020-09-08The Regents Of The University Of CaliforniaImplants using ultrasonic waves for stimulating tissue
US12004840B2 (en)2016-07-072024-06-11The Regents Of The University Of CaliforniaImplants using ultrasonic waves for stimulating tissue
US10187121B2 (en)2016-07-222019-01-22Proteus Digital Health, Inc.Electromagnetic sensing and detection of ingestible event markers
US10797758B2 (en)2016-07-222020-10-06Proteus Digital Health, Inc.Electromagnetic sensing and detection of ingestible event markers
US11793419B2 (en)2016-10-262023-10-24Otsuka Pharmaceutical Co., Ltd.Methods for manufacturing capsules with ingestible event markers
US11529071B2 (en)2016-10-262022-12-20Otsuka Pharmaceutical Co., Ltd.Methods for manufacturing capsules with ingestible event markers
US10675476B2 (en)2016-12-222020-06-09Cardiac Pacemakers, Inc.Internal thoracic vein placement of a transmitter electrode for leadless stimulation of the heart
US11103710B2 (en)2018-06-032021-08-31Olga BOCKERIASystems, methods, and devices for treating bradyarrhythmias, tachyarrhythmias and heart failure
US11654287B2 (en)2019-08-302023-05-23Ebr Systems, Inc.Pulse delivery device including slew rate detector, and associated systems and methods
US12427319B2 (en)2019-08-302025-09-30Ebr Systems, Inc.Pulse delivery device including slew rate detector, and associated systems and methods
US12023488B2 (en)2020-08-172024-07-02Ebr Systems, Inc.Implantable stimulation assemblies having tissue engagement mechanisms, and associated systems and methods
US12350497B2 (en)2022-02-102025-07-08Ebr Systems, Inc.Tissue stimulation systems and methods, such as for pacing cardiac tissue
US12218518B2 (en)2023-04-142025-02-04Ultrapower, Inc.System and method for powering an implantable device using acoustic energy

Also Published As

Publication numberPublication date
WO2001076687A2 (en)2001-10-18
WO2001076687A3 (en)2002-03-21
AU2001251304A1 (en)2001-10-23

Similar Documents

PublicationPublication DateTitle
US6654638B1 (en)Ultrasonically activated electrodes
US6141588A (en)Cardiac simulation system having multiple stimulators for anti-arrhythmia therapy
US9956401B2 (en)Cardiac stimulation using intravascularly-deliverable electrode assemblies
EP3490665B1 (en)System for controlling cardiac pacing mode switching
US7751881B2 (en)Acoustically-powered wireless defibrillator
EP3140000B1 (en)Acoustically triggered therapy delivery
US6907285B2 (en)Implantable defibrillartor with wireless vascular stent electrodes
US5935158A (en)Electrode lead and device for tissue stimulation and/or detection of tissue response
CN107073275B (en)Medical device with triggered blanking period
US8290600B2 (en)Electrical stimulation of body tissue using interconnected electrode assemblies
US20180289948A1 (en)Cardiac stimulation system
US8788035B2 (en)Leadless cardiac pacemaker triggered by conductive communication
US6249709B1 (en)Endocardial defibrillation lead with multi-lumen body and axially mounted distal electrode
US8005551B2 (en)Implantable medical lead
CN108697898B (en) System and method for cardiac pacing
US20090143835A1 (en)Method and apparatus for delivering pacing pulses using a coronary stent
US10675476B2 (en)Internal thoracic vein placement of a transmitter electrode for leadless stimulation of the heart
EP2432551A1 (en)Implantable medical device for cardiac electrical stimulation
EP2257337B1 (en)Atrial defibrillation using an implantable defibrillation system
US12350497B2 (en)Tissue stimulation systems and methods, such as for pacing cardiac tissue

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:CARDIAC PACEMAKERS, INC., MINNESOTA

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SWEENEY, ROBERT J.;REEL/FRAME:011091/0721

Effective date:20000608

FPAYFee payment

Year of fee payment:4

FPAYFee payment

Year of fee payment:8

REMIMaintenance fee reminder mailed
LAPSLapse for failure to pay maintenance fees
STCHInformation on status: patent discontinuation

Free format text:PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FPLapsed due to failure to pay maintenance fee

Effective date:20151125


[8]ページ先頭

©2009-2025 Movatter.jp